Vitamin D: Difference between revisions
rv - too much useful information lost |
|||
Line 2: | Line 2: | ||
[[File:Cholecalciferol-3d.png|thumb|[[Cholecalciferol]] (D<sub>3</sub>)]] |
[[File:Cholecalciferol-3d.png|thumb|[[Cholecalciferol]] (D<sub>3</sub>)]] |
||
[[File:Calcium regulation.png|thumb|[[Human homeostasis#Calcium|Calcium regulation]] in the human body.<ref>{{cite book |chapter=The Parathyroid Glands and Vitamin F |page=1094 |author=Walter F., PhD. Boron |title=Medical Physiology: A Cellular And Molecular Approaoch |publisher=Elsevier/Saunders |location= |year=2003 |isbn=978-1-4160-2328-9}}</ref> The role of vitamin D is shown in orange.]] |
[[File:Calcium regulation.png|thumb|[[Human homeostasis#Calcium|Calcium regulation]] in the human body.<ref>{{cite book |chapter=The Parathyroid Glands and Vitamin F |page=1094 |author=Walter F., PhD. Boron |title=Medical Physiology: A Cellular And Molecular Approaoch |publisher=Elsevier/Saunders |location= |year=2003 |isbn=978-1-4160-2328-9}}</ref> The role of vitamin D is shown in orange.]] |
||
⚫ | '''Vitamin D''' is a group of [[Lipophilicity|fat-soluble]] [[prohormones]], the two major forms of which are [[vitamin]] D<sub>2</sub> (or [[ergocalciferol]]) and vitamin D<sub>3</sub> (or [[cholecalciferol]]).<ref name = FactD>{{cite web|url=http://dietary-supplements.info.nih.gov/factsheets/vitamind.asp|title=Dietary Supplement Fact Sheet: Vitamin D|publisher=National Institutes of Health |accessdate=2007-09-10| archiveurl=http://www.webcitation.org/5Rl5u0LB5 |archivedate=2007-09-10}}</ref> Vitamin D obtained from sun exposure, food, and supplements is biologically inert and must undergo two hydroxylation reactions to be activated in the body. [[Calcitriol]] ([[1,25-Dihydroxycholecalciferol]]) is the active form of vitamin D found in the body. The term vitamin D also refers to these [[metabolite]]s and other analogues of these substances. |
||
⚫ | Calcitriol plays an important role in the maintenance of several [[organ (anatomy)|organ]] systems.<ref name= Merck>{{MerckManual|01|004|k|BABBBEAE|Vitamin D}}</ref> However, its major role is to increase the flow of calcium into the bloodstream, by promoting absorption of [[calcium]] and [[phosphorus]] from food in the [[intestines]], and reabsorption of calcium in the [[kidney]]s; enabling normal mineralization of [[bone]] and preventing [[hypocalcemia|hypocalcemic]] [[Tetany (action potential summation)|tetany]]. It is also necessary for bone growth and bone remodeling by [[osteoblast]]s and [[osteoclast]]s.<ref>{{cite pmid|9023488}}</ref><ref>{{cite pmid|18088161}}</ref> |
||
⚫ | '''Vitamin D''' is a group of [[Lipophilicity|fat-soluble]] [[prohormones]], the two major forms of which are [[vitamin]] D<sub>2</sub> (or [[ergocalciferol]]) and vitamin D<sub>3</sub> (or [[cholecalciferol]]).<ref name= |
||
⚫ | |||
⚫ | Calcitriol plays an important role in the maintenance of several [[organ (anatomy)|organ]] systems.<ref name= |
||
Position Statement by the Scientific Advisory Committee on Nutrition 2007 ISBN 9780112431145</ref><ref> Office of Dietary Supplements • National Institutes of Health Dietary Supplement Fact Sheet: Vitamin D [http://dietary-supplements.info.nih.gov/factsheets/vitamind.asp#en19]</ref> |
|||
⚫ | Vitamin D plays a number of other roles including inhibition of [[calcitonin]] release from the thyroid gland. Calcitonin acts directly on osteoclasts, resulting in inhibition of [[bone resorption]] and cartilage degradation. Vitamin D can also inhibit [[parathyroid hormone]] secretion from the [[parathyroid]] gland and modulate neuromuscular and immune function.<ref>{{cite pmid|3858880}}</ref><ref>{{cite pmid|3771798}}</ref><ref name = SciAmNov2007/> <!--Finally, in the absence of [[vitamin K]] or with drugs (particularly blood thinners) that interfere with Vitamin K metabolism, supraphysiological doses of vitamin D has been shown to promote soft tissue [[calcification]] (in rats).<ref>{{cite pmid|10669626}}</ref> This is not a major or even trivial role of Vitamin D. I don't think it belongs in the lead. --> |
||
⚫ | Up until 51 years of age 200IU is an adequate intake of vitamin D to maintain bone health and normal calcium metabolism in healthy people assuming no synthesis by exposure to sunlight.<ref |
||
⚫ | Vitamin D plays a number of other roles including inhibition of [[calcitonin]] release from the thyroid gland. Calcitonin acts directly on osteoclasts, resulting in inhibition of [[bone resorption]] and cartilage degradation. Vitamin D can also inhibit [[parathyroid hormone]] secretion from the [[parathyroid]] gland and modulate neuromuscular and immune function.<ref>{{cite |
||
== Forms == |
== Forms == |
||
{| class="wikitable" style="width: 40%; float: right; font-size: 90%; margin-left: 25px;" |
{| class="wikitable" style="width: 40%; float: right; font-size: 90%; margin-left: 25px;" |
||
|- style="text-align: center;" |
|||
⚫ | |||
! style="width: 80px;" | Name |
! style="width: 80px;" | Name |
||
! Chemical composition |
! Chemical composition |
||
Line 39: | Line 39: | ||
|} |
|} |
||
Several forms ([[vitamer]]s) of vitamin D have been discovered (see table). The two major forms are vitamin D<sub>2</sub> or [[ergocalciferol]], and vitamin D<sub>3</sub> or [[cholecalciferol]]. These are known collectively as '''calciferol'''.<ref>''Dorland's Illustrated Medical Dictionary'', under Vitamin (Table of Vitamins)</ref> [[Ergocalciferol|Vitamin D<sub>2</sub>]] was chemically characterized in 1932. In 1936 the [[chemical structure]] of [[Cholecalciferol|vitamin D<sub>3</sub>]] was established and resulted from the [[ |
Several forms ([[vitamer]]s) of vitamin D have been discovered (see table). The two major forms are vitamin D<sub>2</sub> or [[ergocalciferol]], and vitamin D<sub>3</sub> or [[cholecalciferol]]. These are known collectively as '''calciferol'''.<ref>''Dorland's Illustrated Medical Dictionary'', under Vitamin (Table of Vitamins)</ref> [[Ergocalciferol|Vitamin D<sub>2</sub>]] was chemically characterized in 1932. In 1936 the [[chemical structure]] of [[Cholecalciferol|vitamin D<sub>3</sub>]] was established and resulted from the [[Ultraviolet|ultraviolet irradiation]] of 7-dehydrocholesterol.<ref>[http://vitamind.ucr.edu/history.html History of Vitamin D] University of California, Riverside, Vitamin D Workshop.</ref> |
||
Chemically, the various forms of vitamin D are [[secosteroids]]; i.e., [[steroid]]s in which one of the bonds in the steroid rings is broken.<ref name= |
Chemically, the various forms of vitamin D are [[secosteroids]]; i.e., [[steroid]]s in which one of the bonds in the steroid rings is broken.<ref name= River>[http://vitamind.ucr.edu/about.html About Vitamin D] Including Sections: History, Nutrition, Chemistry, Biochemistry, and Diseases. University of California Riverside</ref> The structural difference between vitamin D<sub>2</sub> and vitamin D<sub>3</sub> is in their [[side chain]]s. The side chain of D<sub>2</sub> contains a double bond between carbons 22 and 23, and a methyl group on carbon 24. |
||
Vitamin D<sub>2</sub> (made from [[ergosterol]]) is produced by [[invertebrate]]s, [[fungus]] and [[plants]] in response to UV irradiation; it is not produced by [[vertebrate]]s. Little is known about the biologic function of vitamin D<sub>2</sub> in nonvertebrate species. Because ergosterol can more efficiently absorb the ultraviolet radiation that can damage [[DNA]], [[RNA]] and protein it has been suggested that ergosterol serves as a sunscreening system that protects organisms from damaging high energy ultraviolet radiation.<ref name= |
Vitamin D<sub>2</sub> (made from [[ergosterol]]) is produced by [[invertebrate]]s, [[fungus]] and [[plants]] in response to UV irradiation; it is not produced by [[vertebrate]]s. Little is known about the biologic function of vitamin D<sub>2</sub> in nonvertebrate species. Because ergosterol can more efficiently absorb the ultraviolet radiation that can damage [[DNA]], [[RNA]] and protein it has been suggested that ergosterol serves as a sunscreening system that protects organisms from damaging high energy ultraviolet radiation.<ref name= Holick_2004>{{cite pmid|14985208}}</ref> |
||
Vitamin D<sub>3</sub> is made in the skin when [[7-dehydrocholesterol]] reacts with UVB [[ultraviolet light]] at [[wavelengths]] between 270–300 nm, with peak synthesis occurring between 295-297 nm.<ref name= |
Vitamin D<sub>3</sub> is made in the skin when [[7-dehydrocholesterol]] reacts with UVB [[ultraviolet light]] at [[wavelengths]] between 270–300 nm, with peak synthesis occurring between 295-297 nm.<ref name= Norman>{{cite pmid|9625080}}</ref><ref name=MacLaughlin>{{cite pmid|6281884}}</ref> These [[wavelength]]s are present in sunlight when the [[UV index]] is greater than 3. At this solar elevation, which occurs daily within the [[tropics]], daily during the spring and summer seasons in [[temperate region]]s, and almost never within the [[arctic circle]]s, vitamin D<sub>3</sub> can be made in the skin, with prolonged exposure to UVB rays an equilibrium is achieved in the skin, and excess vitamin D simply degrades as fast as it is generated.<ref name="Holick M 1995 638S–645S" /> |
||
=== Production in the skin === |
=== Production in the skin === |
||
[[File:Skinlayers.png|thumb|The epidermal strata of the skin. Production is greatest in the stratum basale (colored red in the illustration) and stratum spinosum (colored orange).]] |
[[File:Skinlayers.png|thumb|The epidermal strata of the skin. Production is greatest in the stratum basale (colored red in the illustration) and stratum spinosum (colored orange).]] |
||
⚫ | The skin consists of two primary layers: the inner layer called the [[dermis]], composed largely of [[connective tissue]], and the outer, thinner [[Epidermis (skin)|epidermis]]. The epidermis consists of five ''strata''; from outer to inner they are: the [[stratum corneum]], [[stratum lucidum]], [[stratum granulosum]], [[stratum spinosum]], and [[stratum basale]]. |
||
[[Cholecalciferol]] is produced photochemically in the [[skin]] from [[7-dehydrocholesterol]]; 7-dehydrocholesterol is produced in relatively large quantities in the skin of most vertebrate animals, including humans.<ref>{{cite pmid|12514284}}</ref> The [[naked mole rat]] appears to be naturally cholecalciferol deficient as serum 25-OH vitamin D levels are undetectable<ref>{{cite pmid|8384476}}</ref> interestingly the naked mole rat is resistant to aging, maintains healthy vascular function<ref>{{cite pmid|17468332}}</ref>and is the longest lived of all rodents.<ref>{{cite pmid|18180931}}</ref><ref>{{cite pmid|18180931}}</ref> |
|||
⚫ | The skin consists of two primary layers: the inner layer called the [[dermis]], composed largely of [[connective tissue]], and the outer, thinner [[ |
||
[[Cholecalciferol]] is produced photochemically in the [[skin]] from [[7-dehydrocholesterol]]; 7-dehydrocholesterol is produced in relatively large quantities in the skin of most vertebrate animals, including humans.<ref>{{cite journal|pmid=12514284|year=2003|last1=Crissey|first1=SD|last2=Ange|first2=KD|last3=Jacobsen|first3=KL|last4=Slifka|first4=KA|last5=Bowen|first5=PE|last6=Stacewicz-Sapuntzakis|first6=M|last7=Langman|first7=CB|last8=Sadler|first8=W|last9=Kahn|first9=S|title=Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos.|volume=133|issue=1|pages=160–6|journal=The Journal of nutrition}}</ref> The [[naked mole rat]] appears to be naturally cholecalciferol deficient as serum 25-OH vitamin D levels are undetectable<ref>{{cite journal|pmid=8384476|year=1993|last1=Yahav|first1=S|last2=Buffenstein|first2=R|title=Cholecalciferol supplementation alters gut function and improves digestibility in an underground inhabitant, the naked mole rat (Heterocephalus glaber), when fed on a carrot diet.|volume=69|issue=1|pages=233–41|journal=The British journal of nutrition}}</ref> interestingly the naked mole rat is resistant to aging, maintains healthy vascular function<ref>{{cite journal|pmid=17468332|year=2007|last1=Csiszar|first1=A|last2=Labinskyy|first2=N|last3=Orosz|first3=Z|last4=Xiangmin|first4=Z|last5=Buffenstein|first5=R|last6=Ungvari|first6=Z|title=Vascular aging in the longest-living rodent, the naked mole rat.|volume=293|issue=2|pages=H919–27|doi=10.1152/ajpheart.01287.2006|journal=American journal of physiology. Heart and circulatory physiology}}</ref> and is the longest lived of all rodents.<ref name="autogenerated439">{{cite journal|pmid=18180931|year=2008|last1=Buffenstein|first1=R|title=Negligible senescence in the longest living rodent, the naked mole-rat: insights from a successfully aging species.|volume=178|issue=4|pages=439–45|doi=10.1007/s00360-007-0237-5|journal=Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology}}</ref><ref name="autogenerated439" /> |
|||
In some animals, the presence of fur or feathers blocks the UV rays from reaching the skin. In birds and fur-bearing mammals, vitamin D is generated from the oily secretions of the skin deposited onto the fur and obtained orally during grooming.<ref>{{cite book |author=Sam D. Stout; Sabrina C. Agarwal; Stout, Samuel D. |title=Bone loss and osteoporosis: an anthropological perspective |publisher=Kluwer Academic/Plenum Publishers |location=New York |year=2003 |isbn=0-306-47767-X}}</ref> |
In some animals, the presence of fur or feathers blocks the UV rays from reaching the skin. In birds and fur-bearing mammals, vitamin D is generated from the oily secretions of the skin deposited onto the fur and obtained orally during grooming.<ref>{{cite book |author=Sam D. Stout; Sabrina C. Agarwal; Stout, Samuel D. |title=Bone loss and osteoporosis: an anthropological perspective |publisher=Kluwer Academic/Plenum Publishers |location=New York |year=2003 |isbn=0-306-47767-X}}</ref> |
||
In 1923, it was established that when [[7-Dehydrocholesterol|7-dehydrocholesterol]] is irradiated with light, a form of a [[fat-soluble]] vitamin is produced. [[Alfred Fabian Hess]] showed that "light equals vitamin D".<ref>[http://www.beyonddiscovery.org/content/view.txt.asp?a=414 UNRAVELING THE ENIGMA OF VITAMIN D] U.S. National Academy of Sciences</ref> [[Adolf Otto Reinhold Windaus|Adolf Windaus]], at the [[University of Göttingen]] in Germany, received the [[Nobel Prize in Chemistry]] in 1928, for his work on the constitution of [[sterol]]s and their connection with vitamins.<ref> |
In 1923, it was established that when [[7-Dehydrocholesterol|7-dehydrocholesterol]] is irradiated with light, a form of a [[fat-soluble]] vitamin is produced. [[Alfred Fabian Hess]] showed that "light equals vitamin D".<ref>[http://www.beyonddiscovery.org/content/view.txt.asp?a=414 UNRAVELING THE ENIGMA OF VITAMIN D] U.S. National Academy of Sciences</ref> [[Adolf Otto Reinhold Windaus|Adolf Windaus]], at the [[University of Göttingen]] in Germany, received the [[Nobel Prize in Chemistry]] in 1928, for his work on the constitution of [[sterol]]s and their connection with vitamins.<ref>[http://nobelprize.org/nobel_prizes/chemistry/laureates/1928/windaus-bio.html Windaus biography at nobelprize.org]</ref> In the 1930s he clarified further the chemical structure of vitamin D. |
||
=== Synthesis mechanism (form 3) === |
=== Synthesis mechanism (form 3) === |
||
{| class="wikitable" |
{| class="wikitable" |
||
| [[7-dehydrocholesterol]], a derivative of [[cholesterol]], is [[photochemistry|photolyzed]] by ultraviolet light in 6-electron [[conrotatory]] [[electrocyclic reaction]]. The product is ''[[previtamin D3|pre-vitamin D<sub>3</sub>]]''<!-- hyphen stays to help reading by novices, please -->. |
| [[7-dehydrocholesterol]], a derivative of [[cholesterol]], is [[photochemistry|photolyzed]] by ultraviolet light in 6-electron [[conrotatory]] [[electrocyclic reaction]]. The product is ''[[previtamin D3|pre-vitamin D<sub>3</sub>]]''<!-- hyphen stays to help reading by novices, please -->. |
||
⚫ | |||
[[File:Reaction-Dehydrocholesterol-PrevitaminD3.png|400px]] |
|||
|- |
|- |
||
| Pre-vitamin D<sub>3</sub> then spontaneously [[isomer]]izes to Vitamin D<sub>3</sub> in a [[antarafacial]] hydride [1,7] [[Sigmatropic shift]]. At room temperature the transformation of previtamin-D<sub>3</sub> to vitamin D<sub>3</sub> takes about 12 days to complete.<ref name= |
| Pre-vitamin D<sub>3</sub> then spontaneously [[isomer]]izes to Vitamin D<sub>3</sub> in a [[antarafacial]] hydride [1,7] [[Sigmatropic shift]]. At room temperature the transformation of previtamin-D<sub>3</sub> to vitamin D<sub>3</sub> takes about 12 days to complete.<ref name= Holick_2004/> |
||
| |
|||
[[File:Reaction-PrevitaminD3-VitaminD3.png|400px]] |
|||
|- |
|- |
||
| Whether it is made in the skin or ingested, vitamin D<sub>3</sub> (cholecalciferol) is then [[hydroxylated]] in the [[liver]] to 25-hydroxycholecalciferol (25(OH)D<sub>3</sub> or [[calcidiol]]) by the enzyme [[25-hydroxylase]] produced by [[hepatocytes]]. This hydroxylation reaction occurs in the endoplasmic reticulum and requires NADPH, O<sub>2</sub> and Mg<sup>2+</sup> yet it is not a cytochrome P450 enzyme. Once made the product is stored in the hepatocytes until it is needed and then can be released into the plasma where it will be bound to an α-globulin. |
| Whether it is made in the skin or ingested, vitamin D<sub>3</sub> (cholecalciferol) is then [[hydroxylated]] in the [[liver]] to 25-hydroxycholecalciferol (25(OH)D<sub>3</sub> or [[calcidiol]]) by the enzyme [[25-hydroxylase]] produced by [[hepatocytes]]. This hydroxylation reaction occurs in the endoplasmic reticulum and requires NADPH, O<sub>2</sub> and Mg<sup>2+</sup> yet it is not a cytochrome P450 enzyme. Once made the product is stored in the hepatocytes until it is needed and then can be released into the plasma where it will be bound to an α-globulin. |
||
25-hydroxycholecalciferol is then transported to the proximal tubules of the kidneys where it can be hydroxylated by one of two enzymes to different forms of vitamin D, one of which is active vitamin D (1,25-OH D) and another which is inactive vitamin D (24,25-OH D). The enzyme [[1α-hydroxylase]] which is activated by [[parathyroid hormone]] (and additionally by low calcium or phosphate) forms the main biologically active vitamin D hormone with a C1 hydroxylation forming 1,25-dihydroxycholecalciferol (1,25(OH)2D<sub>3</sub>, also known as calcitriol). A separate enzyme hydroxylates the C24 atom forming 24R,25(OH)2D<sub>3</sub> when 1α-hydroxylase is not active, this inactivates the molecule from any biological activity. |
25-hydroxycholecalciferol is then transported to the proximal tubules of the kidneys where it can be hydroxylated by one of two enzymes to different forms of vitamin D, one of which is active vitamin D (1,25-OH D) and another which is inactive vitamin D (24,25-OH D). The enzyme [[1α-hydroxylase]] which is activated by [[parathyroid hormone]] (and additionally by low calcium or phosphate) forms the main biologically active vitamin D hormone with a C1 hydroxylation forming 1,25-dihydroxycholecalciferol (1,25(OH)2D<sub>3</sub>, also known as calcitriol). A separate enzyme hydroxylates the C24 atom forming 24R,25(OH)2D<sub>3</sub> when 1α-hydroxylase is not active, this inactivates the molecule from any biological activity. |
||
Calcitriol is represented below right (hydroxylated Carbon 1 is on the lower ring at right, hydroxylated Carbon 25 is at the upper right end). |
Calcitriol is represented below right (hydroxylated Carbon 1 is on the lower ring at right, hydroxylated Carbon 25 is at the upper right end). |
||
| |
|||
[[File:Reaction-VitaminiD3-Calcitriol.png|400px]] |
|||
|} |
|} |
||
=== Mechanism of action === |
=== Mechanism of action === |
||
After vitamin D is produced in the middle layers of skin or consumed in food, it is converted in the [[liver]] and [[kidney]] to form 1,25 dihydroxyvitamin D, (1,25(OH)<sub>2</sub>D), the physiologically active form of vitamin D (when "D" is used without a subscript it refers to either D<sub>2</sub> or D<sub>3</sub>). This physiologically active form of vitamin D is known as calcitriol. Following this conversion, calcitriol is released into the circulation, and by binding to a carrier protein in the [[blood plasma|plasma]], [[vitamin D-binding protein]] (VDBP), it is transported to various target organs.<ref name="River" /> |
After vitamin D is produced in the middle layers of skin or consumed in food, it is converted in the [[liver]] and [[kidney]] to form 1,25 dihydroxyvitamin D, (1,25(OH)<sub>2</sub>D), the physiologically active form of vitamin D (when "D" is used without a subscript it refers to either D<sub>2</sub> or D<sub>3</sub>). This physiologically active form of vitamin D is known as calcitriol. Following this conversion, calcitriol is released into the circulation, and by binding to a carrier protein in the [[blood plasma|plasma]], [[vitamin D-binding protein]] (VDBP), it is transported to various target organs.<ref name="River" /> |
||
The physiologically active form of vitamin D mediates its biological effects by binding to the [[vitamin D receptor]] (VDR), which is principally located in the [[Cell nucleus|nuclei]] of target cells.<ref name= |
The physiologically active form of vitamin D mediates its biological effects by binding to the [[vitamin D receptor]] (VDR), which is principally located in the [[Cell nucleus|nuclei]] of target cells.<ref name= River/> The binding of calcitriol to the VDR allows the VDR to act as a [[transcription factor]] that modulates the [[gene expression]] of transport proteins (such as [[TRPV6]] and [[calbindin]]), which are involved in calcium absorption in the intestine. |
||
The vitamin D receptor belongs to the [[nuclear receptor]] superfamily of [[ |
The vitamin D receptor belongs to the [[nuclear receptor]] superfamily of [[Steroid hormone receptor|steroid/thyroid hormone receptors]], and VDRs are expressed by cells in most [[organ (biology)|organs]], including the [[brain]], [[heart]], [[skin]], [[gonads]], [[prostate]], and [[breast]]. VDR activation in the intestine, bone, kidney, and parathyroid gland cells leads to the maintenance of [[calcium]] and [[phosphorus]] levels in the [[blood]] (with the assistance of [[parathyroid hormone]] and [[calcitonin]]) and to the maintenance of [[bone]] content.<ref name= Sun>{{cite pmid|15585788}}</ref> |
||
The VDR is known to be involved in [[cell proliferation]] and [[cellular differentiation|differentiation]]. Vitamin D also [[#Role in immunomodulation|affects the immune system]], and VDRs are expressed in several [[white blood cell]]s, including [[monocyte]]s and activated [[T cell|T]] and [[B cell]]s.<ref name= |
The VDR is known to be involved in [[cell proliferation]] and [[cellular differentiation|differentiation]]. Vitamin D also [[#Role in immunomodulation|affects the immune system]], and VDRs are expressed in several [[white blood cell]]s, including [[monocyte]]s and activated [[T cell|T]] and [[B cell]]s.<ref name=PDR>[http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0265.shtml Vitamin D] The Physicians Desk Reference. 2006 Thompson Healthcare.</ref> |
||
Apart from VDR activation, various alternative mechanisms of action are known. An important one of these is its role as a natural inhibitor of signal transduction by [[ |
Apart from VDR activation, various alternative mechanisms of action are known. An important one of these is its role as a natural inhibitor of signal transduction by [[Hedgehog signaling pathway|hedgehog]] (a hormone involved in morphogenesis).<ref>{{cite pmid|16895439}}</ref><ref>http://www.medscape.com/viewarticle/713649_3 Hedgehog signaling and Vitamin D</ref> |
||
== Nutrition == |
== Nutrition == |
||
[[File:Cornflakes with milk pouring in.jpg|thumb|Milk and [[cereal grain]]s are often fortified with vitamin D.]] |
[[File:Cornflakes with milk pouring in.jpg|thumb|Milk and [[cereal grain]]s are often fortified with vitamin D.]] |
||
⚫ | Vitamin D is naturally produced by the human body when exposed to direct sunlight. In many countries, such foods as [[milk]], [[yogurt]], [[margarine]], [[Cooking oil|oil spreads]], [[breakfast cereal]], [[pastries]], and [[bread]] are [[food fortification|fortified]] with vitamin D<sub>2</sub> and/or vitamin D<sub>3</sub>.<ref name=Nowson>{{cite pmid|12149085}}</ref> In the United States and Canada, for example, fortified milk typically provides 100 IU per cup, or a quarter of the estimated adequate intake for adults over age 50.<ref name = FactD/><ref name=Holick2>{{cite conference |url=http://www.uvadvantage.org/portals/0/pres/ |title=The Vitamin D Pandemic and its Health Consequences |last1=Holick |first1=Michael |month=May |year=2007 |conference=34th European Symposium on Calcified Tissues |location=Copenhagen}}</ref> |
||
⚫ | Vitamin D is naturally produced by the human body when exposed to direct sunlight. In many countries, such foods as [[milk]], [[yogurt]], [[margarine]], [[Cooking oil|oil spreads]], [[breakfast cereal]], [[pastries]], and [[bread]] are [[food fortification|fortified]] with vitamin D<sub>2</sub> and/or vitamin D<sub>3</sub>.<ref name=Nowson>{{cite |
||
=== Natural sources === |
=== Natural sources === |
||
[[File:Salade de jambon cru et saumon fume.jpg|thumb|Fatty fish, such as salmon, are natural sources of vitamin D.]] |
[[File:Salade de jambon cru et saumon fume.jpg|thumb|Fatty fish, such as salmon, are natural sources of vitamin D.]] |
||
Natural sources of vitamin D include:<ref name="FactD" /> |
Natural sources of vitamin D include:<ref name="FactD" /> |
||
* Fatty fish species, such as: |
* Fatty fish species, such as: |
||
** [[Herring]], 85 g (3 [[ounce]]s (oz)) provides 1383 IU |
** [[Herring]], 85 g (3 [[ounce]]s (oz)) provides 1383 IU |
||
Line 106: | Line 101: | ||
** [[Eel]], cooked, 100 g (3.5 oz), 200 IU |
** [[Eel]], cooked, 100 g (3.5 oz), 200 IU |
||
** Fish liver oils, such as [[cod liver oil]], 1 [[Tablespoon|Tbs.]] (15 ml) provides 1,360 IU (one [[International unit|IU]] equals 25 [[Nanogram|ng]]) |
** Fish liver oils, such as [[cod liver oil]], 1 [[Tablespoon|Tbs.]] (15 ml) provides 1,360 IU (one [[International unit|IU]] equals 25 [[Nanogram|ng]]) |
||
* A whole [[ |
* A whole [[Egg (food)|egg]], provides 20 IU |
||
* Beef liver, cooked, 100 g (3.5 oz), provides 15 IU |
* Beef liver, cooked, 100 g (3.5 oz), provides 15 IU |
||
* [[Mushrooms]] (after UV light exposure)<ref> |
* [[Mushrooms]] (after UV light exposure)<ref>http://articles.latimes.com/2008/mar/31/health/he-eat31</ref><ref>{{cite pmid|19281276}}</ref> |
||
In the [[United States]] (U.S.), typical diets provide about 100 IU/day, the [[NIH]] has set the safe upper limit at 2000 IU/day.<ref> |
In the [[United States]] (U.S.), typical diets provide about 100 IU/day, the [[NIH]] has set the safe upper limit at 2000 IU/day.<ref>[http://ods.od.nih.gov/factsheets/vitamind.asp Dietary Supplement Fact Sheet: Vitamin D]</ref><ref> [http://www.iom.edu/Activities/Nutrition/DRIVitDCalcium.aspx Dietary Reference Intakes for Vitamin D and Calcium]</ref> |
||
=== Measuring vitamin D status === |
=== Measuring vitamin D status === |
||
A blood calcidiol (25-hydroxy-vitamin D) level is a satisfactory way to determine the cumulative effect of sun and diet in relation to vitamin D<ref |
A blood calcidiol (25-hydroxy-vitamin D) level is a satisfactory way to determine the cumulative effect of sun and diet in relation to vitamin D<ref>Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride(1997)., ISBN 978-0-309-06350-0. [http://www.nap.edu/catalog.php?record_id=5776] page 235[http://www.nap.edu/openbook.php?record_id=5776&page=253]</ref> although serum 25(OH)D levels do not indicate the amount of vitamin D stored in other body tissues.<ref name=pmid18689406>{{cite pmid|18689406}}</ref> A concentration of over 15 ng/ml (>37.5 nmol/L) is recommended. Higher levels (>30 ng/ml or >75 nmol/L) are proposed by some as desirable for achieving optimum health but there is not enough evidence to support them.<ref>Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D Position Statement by the Scientific Advisory Committee on Nutrition 2007 ISBN 9780112431145</ref><ref> Office of Dietary Supplements • National Institutes of Health Dietary Supplement Fact Sheet: Vitamin D [http://dietary-supplements.info.nih.gov/factsheets/vitamind.asp#en19]</ref><ref>{{cite pmid|20194237}}</ref><ref>{{cite pmid|20194238}}</ref> A study of highly sun exposed young people in Hawaii concluded that as the highest 25(OH)D concentration produced by natural UV exposure seems to be approximately 60 ng/ml (150nmol/L) this value ought to be seen as the upper limit when prescribing vitamin D supplementation.<ref>{{cite pmid|17426097}}</ref> In a multiethnic cohort there was an increased risk of prostate cancer for those with plasma 25-hydroxyvitamin D of 50ng/ml (125nmol/L)<ref>{{cite pmid|20064705}}</ref> |
||
== Deficiency == |
== Deficiency == |
||
{{Main|Hypovitaminosis D}} |
{{Main|Hypovitaminosis D}} |
||
Low blood calcidiol (25-hydroxy-vitamin D) can result from avoiding the sun although deficiency may also exist in those with abundant exposure to bright sunlight.<ref>{{cite |
Low blood calcidiol (25-hydroxy-vitamin D) can result from avoiding the sun although deficiency may also exist in those with abundant exposure to bright sunlight.<ref>{{cite pmid|18234141}}</ref> Dietary intake supplies a modest amount of vitamin D as few foods contain a significant quantity of vitamin D relative to synthesis in the skin which can supply a large amount. Some genetic diseases have the appearance of rickets,<ref>{{cite pmid|9333115}}</ref><ref>{{cite pmid|12674324}}</ref><ref>{{cite pmid|4542997}}</ref> these are associated with consanguineous marriage.<ref>{{cite pmid|681423}}</ref><ref> {{cite pmid|180907}}</ref><ref>{{cite pmid|4377866}}</ref><ref>{{cite pmid|9486994}}</ref><ref>{{cite doi|10.1097/BCO.0b013e3282b97118}}</ref><ref>{{cite doi|10.1016/j.bone.2009.09.016}}</ref><ref>Vitamin D and rickets By Z. Hochberg</ref> and possibly [[founder effect]].<ref>{{cite pmid|8751865}}</ref> In Kashmir, India patients with pseudovitamin D deficiency rickets had grossly raised 25-hydroxyvitamin D concentrations.<ref>{{cite doi|10.1136/pmj.76.896.369}}</ref> Skin colour has also been associated with low 25(OH)D, especially in Africans living in countries with a temperate climate. For example 25-OHD under 10ng/mL (25 nmol/l) in 44% of asymptomatic East African children living in Melbourne<ref>{{cite pmid|17492073}}</ref><ref>{{cite doi|10.1136/adc.2006.112813}}</ref> However a study of healthy young Ethiopians living in Addis Ababa (10 degrees N) found average 25(OH)D levels of 23.5nmol/L.<ref>{{cite pmid|10526248}}</ref> A review of Vitamin D in Africa<ref>{{cite doi|10.1007/s12018-009-9038-6}}</ref> gives the median levels for [[equatorial]] countries: Kenya 65.5 nmol/L and Zaire 65nmol/L, concluding that it remains to be established if associations between vitamin D status and health outcomes identified in Western countries can be replicated in African countries. |
||
Vitamin D levels are approximately 30% higher in northern Europe than in central and southern Europe, higher vitamin D concentrations in northern countries may have a genetic basis.<ref>{{cite |
Vitamin D levels are approximately 30% higher in northern Europe than in central and southern Europe, higher vitamin D concentrations in northern countries may have a genetic basis.<ref>{{cite pmid|19915719}}</ref><ref name=pmid17287117>{{cite pmid|17287117}}</ref> In a meta-analysis of cross-sectional studies on serum 25(OH)D concentrations globally the levels averaged 54 nmol/l and were higher in women than men, and higher in Caucasians than in non-Caucasians. There was no trend in serum 25(OH)D level with latitude.<ref>{{cite doi|10.1007/s00198-008-0626-y}}</ref> African Americans often have a very low circulating 25(OH)D level, however those of African descent have higher [[parathyroid hormone]] and [[1,25-Dihydroxycholecalciferol]] associated with lower 25-hydroxyvitamin D than other ethnic groups, moreover they have the greatest [[bone density]]<ref>{{cite pmid| 12107201}}</ref> and lowest risk of [[fragility fractures]] compared to other populations.<ref>{{cite pmid|16549493}}</ref><ref>{{cite doi|10.2215/CJN.06361208}}</ref><ref>{{cite pmid|18689399}}</ref> African American adults are less likely to be diagnosed with coronary heart disease,<ref>Office of Minority Health[http://minorityhealth.hhs.gov/templates/content.aspx?ID=3018]</ref> in 2006, 9.4% of white men, 7.8% of black men, and 5.3% of Mexican American men had coronary heart disease,<ref>Dept. Of Health and Human Services [http://www.cdc.gov/DHDSP/library/fs_men_heart.htm]</ref> the NHANES I Epidemiologic Follow-up Study concluded African-American men aged 25 to 74 years had lower age-adjusted rates of coronary heart disease and acute myocardial infarction than white men of the same ages,<ref>{{cite pmid|9229999}}</ref> African Americans have a lower prevalence and extent of coronary artery calcium (CAC) than whites.<ref>{{cite doi|10.1016/j.jcct.2008.12.009}}</ref> The incidence of testicular cancer among African Americans was calculated to be one quarter of that among whites.<ref>{{cite pmid|16140086}}</ref> Frank deficiency of vitamin D can result from a number of [[hereditary]] disorders.<ref name=Merck/> Deficiency results in impaired bone mineralization, and leads to bone softening diseases<ref>{{cite pmid|15989379}}</ref> including: |
||
* [[Rickets]], a childhood disease characterized by impeded growth, and deformity, of the [[long bones]] which can be caused by [[calcium]] or [[phosphorus]] deficiency as well as a lack of vitamin D, today it is largely found in low income counties in Africa, Asia or the Middle East.<ref>{{cite |
* [[Rickets]], a childhood disease characterized by impeded growth, and deformity, of the [[long bones]] which can be caused by [[calcium]] or [[phosphorus]] deficiency as well as a lack of vitamin D, today it is largely found in low income counties in Africa, Asia or the Middle East.<ref>{{cite pmid|17943890}}</ref><ref>{{cite pmid|18214537}}</ref><ref>{{cite pmid|15585795}}</ref> Rickets was first described in the 17th century by [[Francis Glisson]] who stated in 1650 that it had first appeared about 30 years previously in the counties of [[Dorset]] and [[Somerset]].<ref>{{cite pmid|7503834}}</ref> In 1857 [[John Snow (physician)]] suggested the rickets then widespread in Britain was being caused by the adulteration of bakers bread with [[alum]].<ref>{{cite pmid|12777415}}</ref> The role of diet in the development of [[rickets]]<ref>{{cite doi|10.1016/0003-9861(55)90106-5}}</ref><ref>{{cite pmid|5069221}}</ref> was determined by [[Edward Mellanby]] between 1918–1920.<ref name= History>{{cite pmid|12897318}}</ref> By altering the diets of dogs raised in the absence of sunlight, he was able to establish unequivocally that rickets was linked with diet, and identified [[cod liver oil]] as an excellent anti-rachitic agent and [[phytic acid]] as a rachitic agent.<ref>{{cite pmid|16747083}}</ref><ref>{{cite pmid|15395027}}</ref><ref>[http://vitamind.ucr.edu/history.html History of Vitamin D] [[University of California, Riverside]], Vitamin D Workshop.</ref> Nutritional rickets exists in countries with intense year round sunlight such as Nigeria and can occur without vitamin D deficiency.<ref>{{cite pmid|18197991}}</ref><ref>{{cite pmid|10584471}}</ref> In 1921 Elmer McCollum identified a substance found in certain fats that could prevent rickets. Prior to the fortification of milk products with vitamin D, rickets was a major public health problem, in [[Denver]] where [[ultraviolet]] rays are approximately 20% stronger than at sea level on the same latitude<ref>US National Institutes Of Health, National cancer Institute[http://science.education.nih.gov/supplements/nih1/Cancer/activities/activity5_database4.htm]</ref> almost two thirds of 500 children had mild rickets in the late 1920's.<ref>{{cite pmid|4862158}}</ref> An increase in the amount of animal protein<ref>Garrison, R., Jr., Somer, E., The nutrition desk reference(1997)</ref> in the 20th century American diet coupled with consumption of milk<ref>E. Melanie DuPuis., Nature's Perfect Food: How Milk Became America's Drink(2002) ISBN 978-0814719381</ref><ref>{{cite pmid|10232644}}</ref> fortified with relatively small quantities of vitamin D led to a dramatic decline in the number of rickets cases.<ref name= Sun/> Although rickets is now rare in Britain there have been outbreaks in some immigrant communities but<ref>{{cite doi|10.1136/bmj.291.6490.239}}</ref> the sufferers did not conform to the stereotype of concealing clothing. Having darker skin and reduced exposure to sunshine did not produce rickets unless the diet deviated from a Western omnivore pattern characterized by high intakes of meat, fish and eggs, and low intakes of high-extraction [[cereals]].<ref>{{cite pmid|6970590}}</ref> The dietary risk factors for rickets are independent of the low vitamin D content of most foods and appear to result from interactions between constituents of animal foods and the intermediary metabolism of endogenously-synthesized vitamin D.<ref>{{cite pmid|9483661}}</ref> |
||
* [[Osteomalacia]], a bone-thinning disorder that occurs exclusively in adults and is characterized by [[proximal]] muscle weakness and bone fragility. The effects of osteomalacia are thought to contribute to chronic [[musculoskeletal]] [[pain]].<ref>{{cite |
* [[Osteomalacia]], a bone-thinning disorder that occurs exclusively in adults and is characterized by [[proximal]] muscle weakness and bone fragility. The effects of osteomalacia are thought to contribute to chronic [[musculoskeletal]] [[pain]].<ref>{{cite pmid|12520530}}</ref><ref name= pain-topics>{{cite web |author=Stewart B. Leavitt | url=http://pain-topics.org/pdf/vitamind-report.pdf |title= Vitamin D – A Neglected ‘Analgesic’ for Chronic Musculoskeletal Pain |format= |work=Pain-Topics.org |accessdate=2009-03-25}}</ref> but of the five small double-blind randomized controlled trials, only one found a reduction in pain after supplementation, and there is no persuasive evidence of lower vitamin D status in chronic pain sufferers compared to controls.<ref>{{cite pmid|19084336}}</ref> |
||
There are associations between low 25(OH)D levels and many diseases,<ref name="pmid18417640">{{cite |
There are associations between low 25(OH)D levels and many diseases,<ref name="pmid18417640">{{cite pmid|18417640}}</ref>including several [[autoimmune disease]]s.<ref name=SciAmNov2007>{{cite pmid|17990825}}</ref><ref name= Sun/><ref name="pmid18852350">{{cite pmid|18852350}}</ref> However such associations were found in [[observational studies]] and are not conclusive evidence of a causal link, (see [[correlation does not imply causation]]), a systemic review<ref>{{cite pmid|20194237}}</ref> found no significant effect of vitamin D supplements. |
||
One leading<ref>Holick., M., The Vitamin D Solution: A 3- Step Strategy to Cure Our Most Common Health Problem (2010) ISBN 1594630674</ref> proponent of the view that the optimal concentration of 25(OH)D is at least 30 ng/ml |
One leading<ref>Holick., M., The Vitamin D Solution: A 3- Step Strategy to Cure Our Most Common Health Problem (2010) ISBN 1594630674</ref> proponent of the view that the optimal concentration of 25(OH)D is at least 30 ng/ml<ref>{{cite doi|10.1016/j.jacc.2008.08.050}}</ref> defines vitamin D deficiency as a 25(OH)D level of under 20 ng/ml (50 nmol/l), applying this criterion he regards 30% to 50% of the [[United States]] population as suffering from vitamin D deficiency.<ref>{{cite doi|10.1016/j.jacc.2009.02.031}}</ref> This includes areas with abundant sun exposure, such as Hawaii and southern Arizona where over 50% of inhabitants have 25(OH)D level of under 20 ng/ml.<ref>{{cite pmid|18326598}}</ref><ref>{{cite doi|10.1210/jc.2006-2250}}</ref> Such metrics<ref>{{cite pmid|16825677}}</ref> depart from more typical definitions of vitamin deficiency which are based on prevention of overt deficiency symptoms or comparable biologic indicators.<ref>{{cite doi|10.1016/j.jacc.2008.12.070}}</ref><ref>Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride(1997)., ISBN 978-0-309-06350-0. [http://www.nap.edu/catalog.php?record_id=5776] page 235[http://www.nap.edu/openbook.php?record_id=5776&page=253]</ref> |
||
== Overdose by ingestion == |
== Overdose by ingestion == |
||
{{details|hypervitaminosis D}} |
{{details|hypervitaminosis D}} |
||
⚫ | In healthy adults, sustained intake of 1250 micrograms/day (50,000 IU) can produce overt toxicity within months,<ref>Vitamin D. The Merck Manuals Vitamin D [http://www.merck.com/mmpe/sec01/ch004/ch004k.html]</ref> those with certain medical conditions are far more sensitive to vitamin D and develop [[hypercalcaemia]] in response to any increase in vitamin D nutrition while maternal hypercalcaemia during pregnancy may increase foetal sensitivity to effects of vitamin D and lead to a syndrome of mental retardation and facial deformities.<ref>{{cite pmid|10232622}}</ref><ref>[http://www.slv.se/upload/dokument/efsa/upper_level_opinions_full-part33,0.pdf]European Food and Safety authority., Tolerable Upper Intake Limits for Vitamins And Minerals(2006) ISBN 92-9199-014-0</ref> If you have a medical condition, are pregnant or think you may be, or are breastfeeding, you must consult your doctor before taking a vitamin D supplement. For infants (birth to 12 months) the tolerable Upper Limit, (maximum amount that can be tolerated without harm) is set at 25 micrograms/day (1000 IU). 1000 micrograms/day (40,000 IU) in infants has produced toxicity within 1 month.<ref name= Merck/> The U.S. Dietary Reference Intake Tolerable Upper Intake Level (upper limit) of vitamin D for children and adults is set at 50 micrograms/day (2,000 IU). Serum levels of calcidiol (25-hydroxy-vitamin D) are typically used to diagnose vitamin D overdose which is known to cause [[hypercalcemia]] (an elevated level of calcium in the blood) caused by increased intestinal calcium absorption. Vitamin D toxicity is known to be a cause of high blood pressure.<ref>"Complete Guide to Vitamins, Minerals and Supplements", Fisher Books, Tucsan AZ, 1988, p42</ref> [[anorexia (symptom)|anorexia]], [[nausea]], and vomiting. These symptoms are often followed by [[polyuria]] (excessive production of [[urine]]), [[polydipsia]] (increased thirst), weakness, nervousness, [[pruritus]] (itch), and eventually [[renal failure]]. Other signals of kidney disease including elevated protein levels in the urine, [[urinary casts]], and a build up of wastes in the blood stream can also develop.<ref name="Merck" /> In one study, hypercalciuria and bone loss occurred in four patients with documented vitamin D toxicity.<ref>{{cite pmid|9245225}}</ref> Vitamin D toxicity is treated by discontinuing vitamin D supplementation, and restricting calcium intake. If the toxicity is severe blood calcium levels can be further reduced with [[corticosteroid]]s or [[bisphosphonate]]s. Kidney damage may be irreversible. |
||
⚫ | Exposure to sunlight for extended periods of time does not normally cause vitamin D toxicity.<ref name= Vieth>{{cite pmid|10232622}}</ref> This is because within about 20 minutes of ultraviolet exposure in light skinned individuals (3–6 times longer for pigmented skin) the concentration of vitamin D precursors produced in the skin reach an [[Chemical equilibrium|equilibrium]], and any further vitamin D that is produced is degraded.<ref name="Holick M 1995 638S–645S">{{cite pmid|7879731}}</ref> According to some sources, endogenous production with full body exposure to sunlight is approximately 250 µg (10,000 IU) per day.<ref name="Vieth" /> According to Holick, "the skin has a large capacity to produce cholecalciferol"; his experiments indicate that, |
||
⚫ | In healthy adults, sustained intake of 1250 micrograms/day (50,000 IU) can produce overt toxicity within months,<ref>Vitamin D. The Merck Manuals Vitamin D [http://www.merck.com/mmpe/sec01/ch004/ch004k.html]</ref> those with certain medical conditions are far more sensitive to vitamin D and develop [[hypercalcaemia]] in response to any increase in vitamin D nutrition while maternal hypercalcaemia during pregnancy may increase foetal sensitivity to effects of vitamin D and lead to a syndrome of mental retardation and facial deformities.<ref>{{cite |
||
⚫ | Exposure to sunlight for extended periods of time does not normally cause vitamin D toxicity.<ref name= |
||
<blockquote> |
<blockquote> |
||
"[W]hole-body exposure to one minimal [[erythemal]] dose of simulated solar ultraviolet radiation is comparable with taking an oral dose of between 250 and 625 micrograms (10 000 and 25 000 IU) vitamin D."<ref name="Holick M 1995 638S–645S" /> |
"[W]hole-body exposure to one minimal [[erythemal]] dose of simulated solar ultraviolet radiation is comparable with taking an oral dose of between 250 and 625 micrograms (10 000 and 25 000 IU) vitamin D."<ref name="Holick M 1995 638S–645S" /> |
||
</blockquote> |
</blockquote> |
||
It is on the basis of the supposedly similar effect of supplementation and whole body exposure to one [[erythemal]] dose that a leading researcher <ref name="HathcocketalAJCN2007">{{cite |
It is on the basis of the supposedly similar effect of supplementation and whole body exposure to one [[erythemal]] dose that a leading researcher <ref name="HathcocketalAJCN2007">{{cite pmid|17209171}}</ref> has suggested that 250 micrograms/day (10,000 IU) in healthy adults should be adopted as the tolerable upper limit.<ref name="HathcocketalAJCN2007" /> Supplements and skin synthesis have a different effect on on serum 25(OH)D concentrations;<ref>{{cite doi|10.1172/JCI116492}}</ref> endogenously synthesized vitamin D3 travels in plasma almost exclusively on [[vitamin D-binding protein]] (VDBP), providing for a slower hepatic delivery of the vitamin D and the more sustained increase in plasma 25-hydroxycholecalciferol observed after depot, parenteral administration of vitamin D. Yet the orally administered route vitamin D produces swift hepatic delivery of vitamin D, and transient, but nonetheless abrupt, increases in plasma 25-hydroxycholecalciferol. The richest food source of vitamin D — wild salmon — would require 35 ounces a day to provide 10,000IU.<ref>{{cite pmid|17267210}}</ref> It has been argued<ref>[Effects Of Vitamin D and the Natural selection of skin colour:how much vitamin D nutrition are we talking about http://www.direct-ms.org/pdf/VitDVieth/Vieth%20Anthropology%20vit%20D.pdf]</ref> that ingestion of vitamin D in large amounts was achieved in the process of grooming by furry human ancestors and that from UV-exposed human skin secretions early humans ingested vitamin D by licking the skin, however this putative ingestion of vitamin D by early humans is not quantified. A study<ref>{{cite pmid|17855710}}</ref> found 34% of its sample of healthy western Canadians to be be under 40nmol/L at some point and 97% to be under 80nmol/L at least once. It has been questioned.<ref>[Tseng, Lisa. (2003). Controversies in Vitamin D Supplementation. Nutrition Bytes, 9(1) http://escholarship.org/uc/item/4m84d4fn] (Peer reviewed)</ref> whether to ascribe a state of sub-optimal vitamin D status when the annual variation in [[ultraviolet]] will naturally produce a period of falling levels, and such a seasonal decline has been a part of Europeans' adaptive environment<ref>{{cite doi|10.1186/1471-2458-9-22}}</ref> for 1000 generations,<ref>{{cite doi|10.1073/pnas.0903446106}}</ref> is clear thinking. |
||
Still more contentious is recommending supplementation when those supposedly in need of it are labeled healthy and serious doubts exist as to the long term effect of attaining and maintaining serum 25(OH)D of at least 80nmol/L by supplementation.<ref>[Tseng, Lisa. (2003). Controversies in Vitamin D Supplementation. Nutrition Bytes, 9(1) http://escholarship.org/uc/item/4m84d4fn]</ref> Possible ethnic differences in physiological pathways for ingested vitamin D, such as Inuit have, may confound across the board recommendations for vitamin D levels. Inuit compensate for lower production of vitamin D by converting more of this vitamin to its most active form |
Still more contentious is recommending supplementation when those supposedly in need of it are labeled healthy and serious doubts exist as to the long term effect of attaining and maintaining serum 25(OH)D of at least 80nmol/L by supplementation.<ref>[Tseng, Lisa. (2003). Controversies in Vitamin D Supplementation. Nutrition Bytes, 9(1) http://escholarship.org/uc/item/4m84d4fn]</ref> Possible ethnic differences in physiological pathways for ingested vitamin D, such as Inuit have, may confound across the board recommendations for vitamin D levels. Inuit compensate for lower production of vitamin D by converting more of this vitamin to its most active form<ref>{{cite pmid|14708040}}</ref> Another study by the Toronto group<ref>{{cite doi|10.1186/1471-2458-8-336}}</ref> did have 'young Canadian adults of diverse ancestry ' but applied a standard of serum 25(OH)D levels that was significantly higher than official recommedations.<ref>Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D Position Statement by the Scientific Advisory Committee on Nutrition 2007 ISBN 9780112431145</ref><ref> Office of Dietary Supplements • National Institutes of Health Dietary Supplement Fact Sheet: Vitamin D [http://dietary-supplements.info.nih.gov/factsheets/vitamind.asp#en19]</ref>, 75 nmol/L as "optimal", between 75 nmol/L and 50 nmol/L as "insufficient" and < 50 nmol/L as "deficient". The results were ' 22% of individuals of European ancestry had 25(OH)D levels less than the 40 nmol/L cutoff, which is comparable to the values observed in previous studies. 78% of individuals of East Asian ancestry and 77% of individuals of South Asian ancestry had 25(OH)D concentrations lower than 40 nmol/L. The East Asians in the Toronto sample had low 25(OH)D levels when compared to whites. Lipps (2010)<ref>{{cite pmid| 20197091}},</ref> in a world wide review says 'vitamin D deficiency (serum 25(OH)D<25nmol/l) is highly prevalent in China: "A survey in Beijing indicated that Vitamin D-deficiency (plasma 25(OH)D concentration <12.5 nmol/l) occurred in more than 40% of adolescent girls in winter." In a Chinese population at particular risk for [[esophageal cancer]], those with the highest serum 25(OH)D concentrations have a significantly increased risk of the precursor lesion.<ref>{{cite pmid| 17855710}},</ref> [[Inuit]] have relatively high rates of esophageal cancer and there are ethnic differences in the metabolism of vitamin D between Caucasians and Inuit.<ref>{{cite pmid|14708040}},</ref><ref>{{cite pmid|18760245}},</ref> |
||
In South Asians Harinarayan (2009<ref>Harinarayan Vitamin D Status in India – Its Implications and Remedial Measures (2009) [cite http://www.japi.org/january_2009/R-1.html]a review of over 50 studies of 25(OH)D</ref> found "All studies uniformly point to low 25(OH)D levels in the populations studies despite abundant sunshine in our country". For example rural men around Delhi average 44nmol/L. Healthy Indians living at the latitude they are presumably best adapted to seem have low 25(OH)D levels which are not very different from healthy South Asians living in Canada. South Indian patients with ischemic heart disease have serum 25-hydroxyvitamin D3 levels which are extremely high — above 222.5 nmol/l.<ref name= |
In South Asians Harinarayan (2009<ref>Harinarayan Vitamin D Status in India – Its Implications and Remedial Measures (2009) [cite http://www.japi.org/january_2009/R-1.html]a review of over 50 studies of 25(OH)D</ref> found "All studies uniformly point to low 25(OH)D levels in the populations studies despite abundant sunshine in our country". For example rural men around Delhi average 44nmol/L. Healthy Indians living at the latitude they are presumably best adapted to seem have low 25(OH)D levels which are not very different from healthy South Asians living in Canada. South Indian patients with ischemic heart disease have serum 25-hydroxyvitamin D3 levels which are extremely high — above 222.5 nmol/l.<ref name=pmid11949730>{{cite pmid|11949730}}</ref> The Toronto group conclude -"skin pigmentation, assessed by measuring skin melanin content, showed an inverse relationship with serum 25(OH)D". The uniform occurence of very low serum 25(OH)D in Indians living in India and Chinese in China does not support the hypothesis that the low levels seen in the more pigmented are due to lack of synthesis from the sun at higher latitudes, the leader of the study has urged dark-skinned immigrants to take vitamin D supplements nonetheless; "I see no risk, no downside, there's only a potential benefit".<ref>[http://www.cbc.ca/canada/ottawa/story/2010/02/12/ottawa-immigrants-vitamin-d.html CBC Dark-skinned immigrants urged to take vitamin D]Tuesday, February 16, 2010 CBC news</ref><ref>STEPHEN STRAUSS: SCIENCE FRICTION The vitamin D debate Feb. 13, 2008 [http://www.cbc.ca/news/viewpoint/vp_strauss/20080213.html] CBC Analysis and viewpoint</ref> A study of French Canadians<ref>{{cite doi|10.3945/ajcn.2008.26445}}</ref> found that a significant minority did not maximize ingested serum 25(OH)D for genetic reasons; [[vitamin D-binding protein]] polymorphisms explained as much of the variation in circulating 25(OH)D as did total ingestion of vitamin D.<ref>{{cite pmid|8751865}}</ref> Oral vitamin D intake,<ref>{{cite pmid|1385673}}</ref> is lower in Europe than both North America and Scandinavia.<ref>{{cite pmid|8390483}}</ref> Whether the toxicity of oral intake of vitamin D is due to that route being unnatural as suggested by Fraser.<ref name=pmid6132277>{{cite pmid|6132277}}</ref><ref>{{cite pmid|8390483}}</ref> is not known, but there is a certain amount of evidence to suggest that dietary vitamin D may be carried by lipoprotein particles<ref>{{cite doi|10.1258/acb.2009.009018}}</ref> into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages.<ref>{{cite doi|10.2215/CJN.01220308}}</ref> These findings raise questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk. Dietary vitamin D may be causing vascular<ref>{{cite pmid|18519861}},</ref> [[calcification]]. |
||
== Health effects == |
== Health effects == |
||
=== Immune system === |
|||
⚫ | The hormonally active form of vitamin D mediates [[immune system|immunological]] effects by binding to nuclear [[vitamin D receptor]]s (VDR).<ref name= Endo>{{cite pmid|15798098}}</ref> VDR ligands have been shown to increase the activity of [[natural killer cell]]s, and enhance the [[phagocytic]] activity of [[macrophage]]s.<ref name= PDR/> Active vitamin D hormone also increases the production of [[cathelicidin]], an [[antimicrobial peptide]] that is produced in macrophages triggered by bacteria, viruses, and [[fungi]].<ref>Janet Raloff, [http://www.sciencenews.org/articles/20061111/bob9.asp ''The Antibiotic Vitamin''] Science News, Vol 170, November 11, 2006, pages 312-317</ref><ref name="pmid17463418">{{cite pmid|17463418}}</ref><ref>{{cite pmid|9269215}}</ref> |
||
⚫ | A 2006 study published in the [[Journal of the American Medical Association]], reported evidence of a link between Vitamin D deficiency and the onset of [[multiple sclerosis]]; the authors posit that this is due to the immune-response suppression properties of Vitamin D.<ref>{{cite pmid|17179460}}</ref> Further research conducted in 2009 indicates that vitamin D is required to activate a [[histocompatibility]] gene ([[HLA-DRB1]]*1501) necessary for differentiating between self and foreign proteins in a subgroup of individuals genetically predisposed to MS.<ref name="Science News">{{cite web |url=http://www.sciencenews.org/view/generic/id/40626/title/Molecular_link_between_vitamin__D_deficiency_and_MS |title=Science News / Molecular Link Between Vitamin D Deficiency And MS |format= |work= |accessdate=2009-02-25}}</ref> It has been suggested that pregnant women take vitamin D during their pregnancy, to lessen the likelihood of the child developing MS later in life.<ref>[http://news.bbc.co.uk/2/hi/health/7871598.stm Vitamin D helps control MS gene. BBC News. 5 February 2009.]</ref><ref>[http://www.mssociety.ca/en/research/medmmo_20090205.htm Genetic Study Supports Vitamin D Deficiency as an Environmental Factor in MS Susceptibility. Multiple Sclerosis Society of Canada. 5 February 2009]</ref> However vitamin D fortification has been suggested to have caused a pandemic of allergic disease,<ref>{{cite pmid|20016691}},</ref> a study of infants who received supplemental vitamin D found an association between vitamin D supplementation in infancy and an increased risk of atopy and allergic rhinitis later in life.<ref>{{cite pmid|15699498}},</ref> A 2010 study by veteran vitamin D researcher [[Hector DeLuca]] has cast doubt on whether the vitamin D sythesizing effect of UVB is the feature of sunlight that affects MS.<ref>{{Cite doi|10.1073/pnas.1001119107}}</ref> [[Ultraviolet]]- A radiation (which is not involved in synthesis of vitamin D) is known to affect the immune system.<ref>{{Cite doi|10.1039/b9pp00051h}}.</ref><ref>{{Cite doi|10.1111/j.1751-1097.2007.00184.x}}.</ref><ref>{{Cite doi|10.1038/jid.2009.121}}</ref> |
||
=== Immunomodulation === |
|||
⚫ | The hormonally active form of vitamin D mediates [[immune system|immunological]] effects by binding to nuclear [[vitamin D receptor]]s (VDR).<ref name= |
||
⚫ | A 2006 study published in the [[Journal of the American Medical Association]], reported evidence of a link between Vitamin D deficiency and the onset of [[multiple sclerosis]]; the authors posit that this is due to the immune-response suppression properties of Vitamin D.<ref>{{cite |
||
==== Influenza ==== |
==== Influenza ==== |
||
In the [[1918 flu pandemic]] most of the fatalities were healthy young adults and the outbreak was widespread in the summer and autumn (in the Northern Hemisphere). Neither of these facts suggest high vitamin D levels gave any protection, they are actually suggestive of increased mortality for those with higher 25(OH) D concentrations. |
In the [[1918 flu pandemic]] most of the fatalities were healthy young adults and the outbreak was widespread in the summer and autumn (in the Northern Hemisphere). Neither of these facts suggest high vitamin D levels gave any protection, they are actually suggestive of increased mortality for those with higher 25(OH) D concentrations. |
||
=== Cancer === |
=== Cancer === |
||
⚫ | The molecular basis for thinking vitamin D has the potential to prevent [[cancer]] lies in its role as a nuclear [[transcription factor]] that regulates cell growth, differentiation, [[apoptosis]] and a wide range of cellular mechanisms central to the development of cancer.<ref>{{cite pmid|18034918}}</ref> These effects may be mediated through vitamin D receptors expressed in cancer cells.<ref name= PDR/> |
||
⚫ | A 2005 [[Meta-analysis|metastudy]] found correlations between vitamin D levels and and cancer. Drawing from a [[meta-analysis]] of 63 [[observational studies]] of vitamin D status , the authors suggested that intake of an additional 1,000 international units (IU) (or 25 micrograms) of vitamin D daily reduced an individual's [[colon cancer]] risk by 50%, and [[breast cancer|breast]] and [[ovarian cancer]] risks by 30%.<ref>{{Cite pmid|16380576}}</ref><ref>{{cite news| url=http://news.bbc.co.uk/2/hi/health/4563336.stm| title= Vitamin D 'can lower cancer risk'| work=BBC News|date=28 December 2005| accessdate=2006-03-23}}</ref><ref>Gorham ED, Garland CF, Garland FC et al. (2007). "Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. ''Am J Prev Med''. '''32''':210-216.</ref><ref>Garland CF, Mohr SB, Gorham ED et al. (2006). "Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer." ''Am J Prev Med''. '''31''':512-514.</ref> |
||
⚫ | The molecular basis for thinking vitamin D has the potential to prevent [[cancer]] lies in its role as a nuclear [[transcription factor]] that regulates cell growth, differentiation, [[apoptosis]] and a wide range of cellular mechanisms central to the development of cancer.<ref>{{cite |
||
⚫ | A 2005 [[Meta-analysis|metastudy]] found correlations between vitamin D levels and and cancer. Drawing from a [[meta-analysis]] of 63 [[observational studies]] of vitamin D status , the authors suggested that intake of an additional 1,000 international units (IU) (or 25 micrograms) of vitamin D daily reduced an individual's [[colon cancer]] risk by 50%, and [[breast cancer|breast]] and [[ovarian cancer]] risks by 30%.<ref>{{ |
||
A 2006 study using data on over 4 million cancer patients from 13 different countries showed a marked difference in cancer risk between countries classified as sunny and countries classified as less–sunny for a number of different cancers, it has been disputed whether the predictive models used in such studies are accurate in estimating 25(OH)D levels<ref |
A 2006 study using data on over 4 million cancer patients from 13 different countries showed a marked difference in cancer risk between countries classified as sunny and countries classified as less–sunny for a number of different cancers, it has been disputed whether the predictive models used in such studies are accurate in estimating 25(OH)D levels<ref> {{Cite pmid|20219959}}</ref><ref>{{cite pmid|17540555}}</ref> Research has also suggested that cancer patients who have surgery or treatment in the summer — and therefore make more endogenous vitamin D — have a better chance of surviving their cancer than those who undergo treatment in the winter when they are exposed to less sunlight.<ref>{{cite news| url=http://news.bbc.co.uk/2/hi/health/4458085.stm | title= Vitamin D 'aids lung cancer ops' | work=BBC News |date=22 April 2005 | accessdate=2006-03-23}}</ref> However vitamin D levels do not depend on regional solar irradiance<ref> {{Cite pmid|20219959}}</ref> Another 2006 study found that taking the U.S. RDA of vitamin D (400 IU per day) cut the risk of [[pancreatic cancer]] by 43% in a sample of more than 120,000 people from two long-term health surveys.<ref>{{cite pmid|16985031}}</ref><ref>[http://news.bbc.co.uk/1/hi/health/5334534.stm BBC NEWS | Health | Vitamin D 'slashes cancer risk'<!-- Bot generated title -->]</ref> However in male smokers a 3-fold increased risk for pancreatic cancer in the highest compared to lowest [[quintile]] of serum 25-hydroxyvitamin D concentration has been found.<ref>{{doi|10.1158/0008-5472.CAN-06-1876}} |
||
</ref> Research is being done on the use of calcitriol in the medical treatment of patients with advanced [[prostate cancer]].<ref>{{cite pmid|16886675}}</ref> |
|||
[[Polymorphism (biology)|Polymorphisms]] of the [[vitamin D receptor]] (VDR) gene have been associated with an increased risk of breast cancer.<ref name= |
[[Polymorphism (biology)|Polymorphisms]] of the [[vitamin D receptor]] (VDR) gene have been associated with an increased risk of breast cancer.<ref name= Buyru>Buyru N, Tezol A;,Yosunkaya-Fenerci E, Dalay, N. Vitamin D receptor gene polymorphisms in breast cancer. Experimental and Molecular Medicine. 2003; 35(6):550-555.</ref> Impairment of the VDR-mediated gene expression is thought to alter [[mammary gland]] development or function and may predispose cells to [[malignant transformation]]. Women with [[homozygous]] FOK1 mutations in the VDR gene had an increased risk of breast cancer compared with the women who did not. FOK1 mutation has also been associated with decreasing bone mineral density which in turn may be associated with an increase in the risk of breast cancer.<ref>Chen WY, Bertone-Johnson ER, Hunter DJ, [[Walter Willett|Willett WC]], Hankinson SE. Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk. Cancer Epidemiology, Biomarkers, & Prevention. 2005; 14(10):2335-2339.</ref>While low levels of vitamin D in serum have been correlated with [[breast cancer]] disease progression and bone [[metastases]]<ref name= Buyru/> and studies suggest that increased intake of vitamin D reduces the risk of breast cancer in [[premenopausal]] women,<ref name=Lin>Lin J, [[JoAnn E. Manson|Manson JE]], Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Archives of Internal Medicine.2007; 167(10):1050-9,</ref>other studies found no effect on breast or colorectal cancers.<ref>{{cite doi|10.1093/jnci/djn360}}</ref><ref>{{cite pmid| 16467233}},</ref> |
||
A randomized intervention study involving 1,200 women, published in June 2007, reports that vitamin D supplementation (1,100 international units (IU)/day) resulted in a 60% reduction in cancer incidence, during a four-year clinical trial, rising to a 77% reduction for cancers diagnosed ''after'' the first year (and therefore excluding those cancers more likely to have originated prior to the vitamin D intervention).<ref name= |
A randomized intervention study involving 1,200 women, published in June 2007, reports that vitamin D supplementation (1,100 international units (IU)/day) resulted in a 60% reduction in cancer incidence, during a four-year clinical trial, rising to a 77% reduction for cancers diagnosed ''after'' the first year (and therefore excluding those cancers more likely to have originated prior to the vitamin D intervention).<ref name= GlobeAndMail>{{cite news| author= Martin Mittelstaedt| url=http://www.theglobeandmail.com/servlet/story/RTGAM.20070428.wxvitamin28/BNStory/specialScienceandHealth/home | title=Vitamin D casts cancer prevention in new light | work=Global and Mail |date=28 April 2007| accessdate=2007-04-28}}</ref><ref>{{cite pmid|17556697}}</ref> Although the study was criticized on several grounds<ref>{{Cite pmid|18065602}}</ref> including failing to take into account a long term overall increase in cancer found in a another study of vitamin D intake<ref>{{Cite pmid|17549593}}</ref> in 2007 the Canadian Cancer Society, (a national community-based organization of volunteers) recommended that all adults begin taking 1,000 IU per day (five times more than the government says they need) .<ref>[http://www.cancer.ca/ontario/about%20us/media%20centre/od-media%20releases/canadian%20cancer%20society%20announces%20vitamin%20d%20recommendation.aspx?sc_lang=en Canadian Cancer Society announces Vitamin D recommendation, 08 June 2007.]</ref><ref>[http://montreal.ctv.ca/servlet/an/plocal/CTVNews/20070608/cancer_recommendations_070608/20070608/?hub=MontrealHome/canadian%20cancer%20society%20announces%20vitamin%20d%20recommendation.aspx?sc_lang=en Canadian Cancer Society recommends vitamin D. CTV.ca News Staff]</ref> A US [[National Cancer Institute]] study analyzed data from the third national Health and Nutrition Examination Survey to examine the relationship between levels of circulating vitamin D in the blood and cancer mortality in a group of 16,818 participants aged 17 and older. It found no support for an association between 25(OH)D and total cancer mortality,<ref>{{cite pmid|17971526}}</ref> unlike other studies it was done [[Prospective cohort study|prospectively]] – meaning that participants were followed looking forward, and actual blood tests were used to measure the amount of vitamin D in their blood rather than than by trying to infer vitamin D levels from predictive models which may be inaccurate.<ref>{{cite doi|10.1093/jnci/djm235}}</ref><ref> {{Cite pmid|20219959}}</ref><ref>Maybe Vitamin D Isn't The Answer After All[http://jnci.oxfordjournals.org/cgi/content/full/99/21/1561-a]</ref> |
||
=== Cardiovascular disease === |
=== Cardiovascular disease === |
||
⚫ | There is a certain amount of evidence to suggest that dietary vitamin D may be carried by lipoprotein particles<ref>{{cite doi|10.1258/acb.2009.009018}}</ref> into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages.<ref>{{cite doi|10.2215/CJN.01220308}}</ref> These findings raise questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk. Dietary vitamin D may be causing vascular<ref>{{cite pmid|18519861}},</ref> [[calcification]]. Low levels of vitamin D are associated with an increase in [[high blood pressure]] and [[cardiovascular]] risk. Numerous [[observational study|observational studies]] show this link, but of two systemic reviews one found only weak evidence of benefit from supplements and the other found no evidence of a beneficial effect whatsoever.<ref>{{cite pmid|20194237}}</ref><ref>{{cite pmid|20194238}}</ref><ref name = nemerovski>{{cite pmid|19476421}}</ref> The precise mechanism for cardiovascular regulation is still under investigation; possibilities include [[blood pressure]] regulation through the [[renin-angiotensin system]], [[parathyroid hormone]] levels, direct impact on heart muscle function, [[inflammation]], and [[vascular system|vascular]] calcification.<ref>{{cite pmid|19852887}}</ref> |
||
⚫ | When researchers monitored the vitamin D levels, blood pressure and other cardiovascular risk factors of 1739 people, of an average age of 59 years for 5 years, they found that those people with low levels of vitamin D had a 62% higher risk of a cardiovascular event than those with normal vitamin D levels.<ref>{{cite pmid|18180395}}</ref> Low levels of vitamin D have also been [[Correlation and dependence|correlated]] with [[hypertension]], elevated VLDL triglycerides, and impaired insulin metabolism.<ref name="pmid8541004">{{cite pmid|8541004}}</ref> |
||
⚫ | There is a certain amount of evidence to suggest that dietary vitamin D may be carried by lipoprotein particles<ref |
||
A report from the [[National Health and Nutrition Examination Survey]] (NHANES) involving nearly 5,000 participants found that low levels of vitamin D were associated with an increased risk of [[peripheral artery disease]] (PAD). The incidence of PAD was 80% higher in participants with the lowest vitamin D levels (<17.8 [[ng]]/[[mL]]).<ref name="pmid18417640" /> Cholesterol levels were found to be reduced in gardeners in the UK during the summer months.<ref>{{cite pmid|8935479}}</ref> [[Heart attack]]s peak in winter and decline in summer in temperate<ref>{{cite pmid|9581712}}</ref> but not tropical latitudes.<ref>{{cite doi|10.1016/S0735-1097(98)00098-9}}</ref> [[Calcifediol]] (25-hydroxy-vitamin D) is implicated in the etiology of atherosclerosis, especially in non-Caucasians.<ref name=pmid6132277/><ref>{{cite journal |first=Lisa |last=Tseng |year=2003 |title=Controversies in Vitamin D Supplementation |journal=Nutrition Bytes |volume=9 |issue=1 |url=http://escholarship.org/uc/item/4m84d4fn}}</ref><ref name=pmid11949730/><ref>{{cite doi|10.1210/jc.2009-1797}}</ref> Vitamin D levels are generally higher in the physically fit but are lower in those of tropical origin, this is a confound for any attempt to make a worldwide recommendation for vitamin D.<ref>{{cite pmid|7487689}}</ref> [[1,25-Dihydroxycholecalciferol]](active serum vitamin D) levels are inversely correlated with coronary calcification<ref>{{cite pmid|9323058}}</ref> moreover one-alpha-hydroxy-cholecalciferol, an active vitamin D analog<ref>{{cite pmid|19232159}}</ref> therapy seems to protect patients from developing vascular calcification.<ref>{{cite pmid|20091391}}</ref> African Americans have higher active serum vitamin D levels.<ref>{{cite pmid|3839801}}</ref><ref>{{cite pmid|18290719}}</ref><ref>{{cite pmid|15585802}}</ref> There are racial differences in the association of coronary calcified plaque<ref name=pmid16679080>{{cite pmid|16679080}}</ref> in that there is less calcified atherosclerotic plaque in the coronary arteries of African-Americans than in whites. One study found an elevated risk of [[ischaemic heart disease]] in Southern India in individuals whose vitamin D levels were above 89 ng/mL.<ref name=pmid11949730/> Freedman et al. (2010) have found that serum vitamin D correlates in African Americans, but not in Euro-Americans, with calcified atheroscleratic plaque. ''Pharmacokinetics of vitamin D toxicity'' states - "Early assumptions that 1,25(OH)2D3 might cause hypercalcemia in vitamin D toxicity have been replaced by the theories that 25(OH)D3 at pharmacologic concentrations can overcome vitamin D receptor affinity disadvantages to directly stimulate transcription or that total vitamin D metabolite concentrations displace 1,25(OH)2D from vitamin D binding".<ref name=pmid18689406/> Freedman et al. (2010) states - "Higher levels of 25-hydroxyvitamin D seem to be positively correlated with aorta and carotid CP in African Americans but not with coronary CP. These results contradict what is observed in individuals of European descent".<ref>{{cite doi|10.1210/jc.2009-1797}}</ref> Recommendations stemming for a single standard for optimal serum 25(OH)D concentrations ignores the differing genetically mediated determinates of serum 25(OH)D and may result in ethnic minorities in Western countries having the results of studies done with subjects not representative of ethnic diversity applied to them. Vitamin D levels vary for genetically mediated reasons as well as environmental ones.<ref>{{cite pmid|18593774}}</ref><ref>{{cite pmid|19116321}}</ref><ref>{{cite pmid|8740896}}</ref><ref name=pmid17287117/><ref>{{cite pmid|19303961}},</ref><ref>{{cite doi|10.1172/JCI111995}}</ref><ref>{{cite pmid|8547833}}</ref><ref name=pmid16679080/><ref>{{cite pmid|19926773}}</ref> Among descent groups with heavy sun exposure during their evolution, taking supplemental vitamin D to attain the 25(OH)D level associated with optimal health in studies done with mainly European populations may have deleterious outcomes.<ref>[http://escholarship.org/uc/item/4m84d4fn Tseng, L., (2003) Controversies in Vitamin D Supplementation]</ref> A review of vitamin D status in India concluded that studies uniformly point to low 25(OH)D levels in Indians despite abundant sunshine, and suggested a public health need to fortify Indian foods with vitamin D might exist. However the levels found in India are consistent with many other studies of tropical populations which have found that even an extreme amount of sun exposure, such as incured by rural Indians,<ref>{{cite pmid|19263699}}</ref> does not raise 25(OH)D levels to the levels typically found in Europeans,<ref>{{cite pmid|20197091}}</ref><ref>{{cite doi|10.1017/S0007114508898662}}</ref><ref>{{cite pmid|18458986}}</ref><ref>{{cite pmid|20062904}}</ref><ref>{{cite pmid|20074396}}</ref><ref>{{cite pmid|19753759}}</ref><ref>{{cite doi|10.1007/s00198-003-1491-3}}</ref> |
|||
⚫ | When researchers monitored the vitamin D levels, blood pressure and other cardiovascular risk factors of 1739 people, of an average age of 59 years for 5 years, they found that those people with low levels of vitamin D had a 62% higher risk of a cardiovascular event than those with normal vitamin D levels.<ref>{{cite |
||
A report from the [[National Health and Nutrition Examination Survey]] (NHANES) involving nearly 5,000 participants found that low levels of vitamin D were associated with an increased risk of [[peripheral artery disease]] (PAD). The incidence of PAD was 80% higher in participants with the lowest vitamin D levels (<17.8 [[ng]]/[[mL]]).<ref name="pmid18417640" /> Cholesterol levels were found to be reduced in gardeners in the UK during the summer months.<ref>{{cite journal|pmid=8935479|year=1996|last1=Grimes|first1=DS|last2=Hindle|first2=E|last3=Dyer|first3=T|title=Sunlight, cholesterol and coronary heart disease.|volume=89|issue=8|pages=579–89|journal=QJM : monthly journal of the Association of Physicians}}</ref> [[Heart attack]]s peak in winter and decline in summer in temperate<ref>{{cite journal|pmid=9581712|year=1998|last1=Spencer|first1=FA|last2=Goldberg|first2=RJ|last3=Becker|first3=RC|last4=Gore|first4=JM|title=Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction.|volume=31|issue=6|pages=1226–33|journal=Journal of the American College of Cardiology}}</ref> but not tropical latitudes.<ref>{{cite journal|doi=10.1016/S0735-1097(98)00098-9|title=Seasonal Distribution of Acute Myocardial Infarction in the Second National Registry of Myocardial Infarction|year=1998|last1=Spencer|first1=F|journal=Journal of the American College of Cardiology|volume=31|page=1226}}</ref> [[Calcifediol]] (25-hydroxy-vitamin D) is implicated in the etiology of atherosclerosis, especially in non — Caucasians.<ref name="pmid6132277" /><ref name="escholarship2003">{{cite web|url=http://escholarship.org/uc/item/4m84d4fn |title=Tseng, L., (2003) Controversies in Vitamin D Supplementation |publisher=Escholarship.org |date=2003-01-01 |accessdate=2010-03-25}}</ref><ref name="pmid11949730" /><ref name="atherosclerotic1076">{{cite journal|doi=10.1210/jc.2009-1797|title=Vitamin D, Adiposity, and Calcified Atherosclerotic Plaque in African-Americans|year=2010|last1=Freedman|first1=B. I.|last2=Wagenknecht|first2=L. E.|last3=Hairston|first3=K. G.|last4=Bowden|first4=D. W.|last5=Carr|first5=J. J.|last6=Hightower|first6=R. C.|last7=Gordon|first7=E. J.|last8=Xu|first8=J.|last9=Langefeld|first9=C. D.|journal=Journal of Clinical Endocrinology & Metabolism|volume=95|page=1076}}</ref> Vitamin D levels are generally higher in the physically fit but are lower in those of tropical origin, this is a confound for any attempt to make a worldwide recommendation for vitamin D.<ref>{{cite journal|pmid=7487689|year=1995|last1=Scragg|first1=R|last2=Holdaway|first2=I|last3=Singh|first3=V|last4=Metcalf|first4=P|last5=Baker|first5=J|last6=Dryson|first6=E|title=Serum 25-hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforce.|volume=25|issue=3|pages=218–23|journal=Australian and New Zealand journal of medicine}}</ref> [[1,25-Dihydroxycholecalciferol]](active serum vitamin D) levels are inversely correlated with coronary calcification<ref>{{cite journal|pmid=9323058|year=1997|last1=Watson|first1=KE|last2=Abrolat|first2=ML|last3=Malone|first3=LL|last4=Hoeg|first4=JM|last5=Doherty|first5=T|last6=Detrano|first6=R|last7=Demer|first7=LL|title=Active serum vitamin D levels are inversely correlated with coronary calcification.|volume=96|issue=6|pages=1755–60|journal=Circulation}}</ref> moreover one-alpha-hydroxy-cholecalciferol, an active vitamin D analog<ref>{{cite journal|pmid=19232159|year=2008|last1=Brandi|first1=L|title=1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.|volume=55|issue=4|pages=186–210|journal=Danish medical bulletin}}</ref> therapy seems to protect patients from developing vascular calcification.<ref>{{cite journal|pmid=20091391|year=2010|last1=Ogawa|first1=T|last2=Ishida|first2=H|last3=Akamatsu|first3=M|last4=Matsuda|first4=N|last5=Fujiu|first5=A|last6=Ito|first6=K|last7=Ando|first7=Y|last8=Nitta|first8=K|title=Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients.|volume=25|issue=1|pages=1–6|doi=10.1007/s00380-009-1151-4|journal=Heart and vessels}}</ref> African Americans have higher active serum vitamin D levels.<ref>{{cite journal|pmid=3839801|year=1985|last1=Bell|first1=NH|last2=Greene|first2=A|last3=Epstein|first3=S|last4=Oexmann|first4=MJ|last5=Shaw|first5=S|last6=Shary|first6=J|title=Evidence for alteration of the vitamin D-endocrine system in blacks.|volume=76|issue=2|pages=470–3|doi=10.1172/JCI111995|pmc=423843|journal=The Journal of clinical investigation}}</ref><ref>{{cite journal|pmid=18290719|year=2007|last1=Cosman|first1=F|last2=Nieves|first2=J|last3=Dempster|first3=D|last4=Lindsay|first4=R|title=Vitamin D economy in blacks.|volume=22 Suppl 2|pages=V34–8|doi=10.1359/jbmr.07s220|journal=Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research}}</ref><ref>{{cite journal|pmid=15585802|year=2004|last1=Dawson-Hughes|first1=B|title=Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women.|volume=80|issue=6 Suppl|pages=1763S–6S|journal=The American journal of clinical nutrition}}</ref> There are racial differences in the association of coronary calcified plaque<ref name="pmid16679080">{{cite journal|pmid=16679080|year=2006|last1=Tang|first1=W|last2=Arnett|first2=DK|last3=Province|first3=MA|last4=Lewis|first4=CE|last5=North|first5=K|last6=Carr|first6=JJ|last7=Pankow|first7=JS|last8=Hopkins|first8=PN|last9=Devereux|first9=RB|title=Racial differences in the association of coronary calcified plaque with left ventricular hypertrophy: the National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network.|volume=97|issue=10|pages=1441–8|doi=10.1016/j.amjcard.2005.11.076|journal=The American journal of cardiology}}</ref> in that there is less calcified atherosclerotic plaque in the coronary arteries of African-Americans than in whites. One study found an elevated risk of [[ischaemic heart disease]] in Southern India in individuals whose vitamin D levels were above 89 ng/mL.<ref name="pmid11949730" /> Freedman et al. (2010) have found that serum vitamin D correlates in African Americans, but not in Euro-Americans, with calcified atheroscleratic plaque. ''Pharmacokinetics of vitamin D toxicity'' states - "Early assumptions that 1,25(OH)2D3 might cause hypercalcemia in vitamin D toxicity have been replaced by the theories that 25(OH)D3 at pharmacologic concentrations can overcome vitamin D receptor affinity disadvantages to directly stimulate transcription or that total vitamin D metabolite concentrations displace 1,25(OH)2D from vitamin D binding".<ref name="pmid18689406" /> Freedman et al. (2010) states - "Higher levels of 25-hydroxyvitamin D seem to be positively correlated with aorta and carotid CP in African Americans but not with coronary CP. These results contradict what is observed in individuals of European descent".<ref name="atherosclerotic1076" /> Recommendations stemming for a single standard for optimal serum 25(OH)D concentrations ignores the differing genetically mediated determinates of serum 25(OH)D and may result in ethnic minorities in Western countries having the results of studies done with subjects not representative of ethnic diversity applied to them. Vitamin D levels vary for genetically mediated reasons as well as environmental ones.<ref>{{cite journal|pmid=18593774|year=2008|last1=Engelman|first1=CD|last2=Fingerlin|first2=TE|last3=Langefeld|first3=CD|last4=Hicks|first4=PJ|last5=Rich|first5=SS|last6=Wagenknecht|first6=LE|last7=Bowden|first7=DW|last8=Norris|first8=JM|title=Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans.|volume=93|issue=9|pages=3381–8|doi=10.1210/jc.2007-2702|pmc=2567851|journal=The Journal of clinical endocrinology and metabolism}}</ref><ref>{{cite journal|pmid=19116321|year=2009|last1=Sinotte|first1=M|last2=Diorio|first2=C|last3=Bérubé|first3=S|last4=Pollak|first4=M|last5=Brisson|first5=J|title=Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women.|volume=89|issue=2|pages=634–40|doi=10.3945/ajcn.2008.26445|journal=The American journal of clinical nutrition}}</ref><ref>{{cite journal|pmid=8740896|year=1995|last1=Creemers|first1=PC|last2=Du Toit|first2=ED|last3=Kriel|first3=J|title=DBP (vitamin D binding protein) and BF (properdin factor B) allele distribution in Namibian San and Khoi and in other South African populations.|volume=9|issue=3|pages=185–9|journal=Gene geography : a computerized bulletin on human gene frequencies}}</ref><ref name="pmid17287117" /><ref>{{cite journal|pmid=19303961|year=2009|last1=Winters|first1=SJ|last2=Chennubhatla|first2=R|last3=Wang|first3=C|last4=Miller|first4=JJ|title=Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women.|volume=58|issue=4|pages=438–42|doi=10.1016/j.metabol.2008.10.017|journal=Metabolism: clinical and experimental}}</ref><ref>{{cite journal|doi=10.1172/JCI111995|title=Evidence for alteration of the vitamin D-endocrine system in blacks.|year=1985|last1=Bell|first1=N H|last2=Greene|first2=A|last3=Epstein|first3=S|last4=Oexmann|first4=M J|last5=Shaw|first5=S|last6=Shary|first6=J|journal=Journal of Clinical Investigation|volume=76|page=470}}</ref><ref>{{cite journal|pmid=8547833|year=1995|last1=Corder|first1=EH|last2=Friedman|first2=GD|last3=Vogelman|first3=JH|last4=Orentreich|first4=N|title=Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men.|volume=4|issue=6|pages=655–9|journal=Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology}}</ref><ref name="pmid16679080" /><ref>{{cite journal|pmid=19926773|year=2010|last1=Borges|first1=CR|last2=Rehder|first2=DS|last3=Jarvis|first3=JW|last4=Schaab|first4=MR|last5=Oran|first5=PE|last6=Nelson|first6=RW|title=Full-length characterization of proteins in human populations.|volume=56|issue=2|pages=202–11|doi=10.1373/clinchem.2009.134858|journal=Clinical chemistry}}</ref> Among descent groups with heavy sun exposure during their evolution, taking supplemental vitamin D to attain the 25(OH)D level associated with optimal health in studies done with mainly European populations may have deleterious outcomes.<ref name="escholarship2003" /> A review of vitamin D status in India concluded that studies uniformly point to low 25(OH)D levels in Indians despite abundant sunshine, and suggested a public health need to fortify Indian foods with vitamin D might exist. However the levels found in India are consistent with many other studies of tropical populations which have found that even an extreme amount of sun exposure, such as incured by rural Indians,<ref>{{cite journal|pmid=19263699|year=2008|last1=Goswami|first1=R|last2=Kochupillai|first2=N|last3=Gupta|first3=N|last4=Goswami|first4=D|last5=Singh|first5=N|last6=Dudha|first6=A|title=Presence of 25(OH) D deficiency in a rural North Indian village despite abundant sunshine.|volume=56|pages=755–7|journal=The Journal of the Association of Physicians of India}}</ref> does not raise 25(OH)D levels to the levels typically found in Europeans.<ref>{{cite journal|pmid=20197091|year=2010|last1=Lips|first1=P|title=Worldwide status of vitamin D nutrition.|doi=10.1016/j.jsbmb.2010.02.021|journal=The Journal of steroid biochemistry and molecular biology}}</ref><ref>{{cite journal|doi=10.1017/S0007114508898662|title=Abundant sunshine and vitamin D deficiency|year=2008|last1=Schoenmakers|first1=Inez|last2=Goldberg|first2=Gail R.|last3=Prentice|first3=Ann|journal=British Journal of Nutrition|volume=99}}</ref><ref>{{cite journal|pmid=18458986|year=2009|last1=Hagenau|first1=T|last2=Vest|first2=R|last3=Gissel|first3=TN|last4=Poulsen|first4=CS|last5=Erlandsen|first5=M|last6=Mosekilde|first6=L|last7=Vestergaard|first7=P|title=Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis.|volume=20|issue=1|pages=133–40|doi=10.1007/s00198-008-0626-y|journal=Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA}}</ref><ref>{{cite journal|pmid=20062904|year=2010|last1=Mahdy|first1=S|last2=Al-Emadi|first2=SA|last3=Khanjar|first3=IA|last4=Hammoudeh|first4=MM|last5=Sarakbi|first5=HA|last6=Siam|first6=AM|last7=Abdelrahman|first7=MO|title=Vitamin D status in health care professionals in Qatar.|volume=31|issue=1|pages=74–7|journal=Saudi medical journal}}</ref><ref>{{cite journal|pmid=20074396|year=2010|last1=Hamilton|first1=B|last2=Grantham|first2=J|last3=Racinais|first3=S|last4=Chalabi|first4=H|title=Vitamin D deficiency is endemic in Middle Eastern sportsmen.|pages=1–7|doi=10.1017/S136898000999320X|journal=Public health nutrition}}</ref><ref>{{cite journal|pmid=19753759|year=2009|last1=Harinarayan|first1=CV|last2=Joshi|first2=SR|title=Vitamin D status in India--its implications and remedial measures.|volume=57|pages=40–8|journal=The Journal of the Association of Physicians of India}}</ref><ref>{{cite journal|doi=10.1007/s00198-003-1491-3|title=Vitamin D status and its relationship with bone mineral density in healthy Asian Indians|year=2004|last1=Arya|first1=Vivek|last2=Bhambri|first2=Rajiv|last3=Godbole|first3=Madan M.|last4=Mithal|first4=Ambrish|journal=Osteoporosis International|volume=15|page=56}}</ref> |
|||
=== Mortality === |
=== Mortality === |
||
⚫ | Using information from the [[National Health and Nutrition Examination Survey]] a group of researchers concluded that having low levels of vitamin D (<17.8 ng/ml) was independently associated with an increase in all-cause mortality in the general population.<ref>{{cite pmid|18695076}}</ref> The study evaluated whether low serum vitamin D levels were associated with all-cause mortality, cancer, and cardiovascular disease (CVD) mortality among 13,331 diverse American adults who were 20 years or older. Vitamin D levels of these participants were collected over a 6-year period (from 1988 through 1994), and individuals were passively followed for mortality through the year 2000. Shortening of [[leukocyte]] telomeres is a marker of aging. Leukocyte telomere length (LTL) predicts the development of aging-related disease, and length of these telomeres decreases with each cell division and with increased inflammation (more common in the elderly). Vitamin D can inhibit [[proinflammatory]] overeaction and slow the turnover of leukocytes, longer [[leukocyte]] telomere length is achieved by the body maintaining the optimal vitamin D concentration.<ref>{{cite pmid|17991655}}</ref> |
||
Complex regulatory mechanisms control metabolism, recent epidemiologic evidence suggests that there is a narrow range of vitamin D levels in which vascular function is optimized. Levels above or below this natural [[human homeostasis|homeostasis]] of vitamin D increase mortality.<ref>{{cite doi|10.2215/CJN.01220308}}</ref> Overall, excess or deficiency in the calcipherol system appear to cause abnormal functioning and premature aging.<ref>{{cite pmid|19444937}}</ref><ref>{{cite pmid|19500727}}</ref><ref>{{cite pmid|19660871}}</ref> |
|||
⚫ | Using information from the [[National Health and Nutrition Examination Survey]] a group of researchers concluded that having low levels of vitamin D (<17.8 ng/ml) was independently associated with an increase in all-cause mortality in the general population.<ref>{{cite |
||
Complex regulatory mechanisms control metabolism, recent epidemiologic evidence suggests that there is a narrow range of vitamin D levels in which vascular function is optimized. Levels above or below this natural [[human homeostasis|homeostasis]] of vitamin D increase mortality.<ref name="differentiation1542" /> Overall, excess or deficiency in the calcipherol system appear to cause abnormal functioning and premature aging.<ref>{{cite journal|pmid=19444937|year=2009|last1=Tuohimaa|first1=P|title=Vitamin D and aging.|volume=114|issue=1-2|pages=78–84|journal=The Journal of steroid biochemistry and molecular biology}}</ref><ref>{{cite journal|pmid=19500727|year=2009|last1=Keisala|first1=T|last2=Minasyan|first2=A|last3=Lou|first3=YR|last4=Zou|first4=J|last5=Kalueff|first5=AV|last6=Pyykkö|first6=I|last7=Tuohimaa|first7=P|title=Premature aging in vitamin D receptor mutant mice.|volume=115|issue=3-5|pages=91–7|doi=10.1016/j.jsbmb.2009.03.007|journal=The Journal of steroid biochemistry and molecular biology}}</ref><ref>{{cite journal|pmid=19660871|year=2009|last1=Tuohimaa|first1=P|last2=Keisala|first2=T|last3=Minasyan|first3=A|last4=Cachat|first4=J|last5=Kalueff|first5=A|title=Vitamin D, nervous system and aging.|volume=34 Suppl 1|pages=S278–86|doi=10.1016/j.psyneuen.2009.07.003|journal=Psychoneuroendocrinology}}</ref> |
|||
== See also == |
== See also == |
||
* [[Marshall Protocol]] |
* [[Marshall Protocol]] |
||
* [[Mushrooms and Vitamin D]] |
* [[Mushrooms and Vitamin D]] |
||
Line 190: | Line 176: | ||
== References == |
== References == |
||
⚫ | |||
⚫ | |||
== External links == |
== External links == |
||
* [http://ods.od.nih.gov/factsheets/vitamind.asp Vitamin D Fact Sheet] from the [[U.S.]] [[National Institutes of Health]] |
* [http://ods.od.nih.gov/factsheets/vitamind.asp Vitamin D Fact Sheet] from the [[U.S.]] [[National Institutes of Health]] |
||
* {{dmoz|Health/Nutrition/Nutrients/Vitamins_and_Minerals/Vitamin_D/}} |
* {{dmoz|Health/Nutrition/Nutrients/Vitamins_and_Minerals/Vitamin_D/}} |
Revision as of 19:02, 25 March 2010
Vitamin D is a group of fat-soluble prohormones, the two major forms of which are vitamin D2 (or ergocalciferol) and vitamin D3 (or cholecalciferol).[2] Vitamin D obtained from sun exposure, food, and supplements is biologically inert and must undergo two hydroxylation reactions to be activated in the body. Calcitriol (1,25-Dihydroxycholecalciferol) is the active form of vitamin D found in the body. The term vitamin D also refers to these metabolites and other analogues of these substances.
Calcitriol plays an important role in the maintenance of several organ systems.[3] However, its major role is to increase the flow of calcium into the bloodstream, by promoting absorption of calcium and phosphorus from food in the intestines, and reabsorption of calcium in the kidneys; enabling normal mineralization of bone and preventing hypocalcemic tetany. It is also necessary for bone growth and bone remodeling by osteoblasts and osteoclasts.[4][5]
Up until 51 years of age 200IU is an adequate intake of vitamin D to maintain bone health and normal calcium metabolism in healthy people assuming no synthesis by exposure to sunlight.[6][7]
Vitamin D plays a number of other roles including inhibition of calcitonin release from the thyroid gland. Calcitonin acts directly on osteoclasts, resulting in inhibition of bone resorption and cartilage degradation. Vitamin D can also inhibit parathyroid hormone secretion from the parathyroid gland and modulate neuromuscular and immune function.[8][9][10]
Forms
Name | Chemical composition | Structure |
---|---|---|
Vitamin D1 | molecular compound of ergocalciferol with lumisterol, 1:1 | |
Vitamin D2 | ergocalciferol (made from ergosterol) | |
Vitamin D3 | cholecalciferol (made from 7-dehydrocholesterol in the skin). | |
Vitamin D4 | 22-dihydroergocalciferol | |
Vitamin D5 | sitocalciferol (made from 7-dehydrositosterol) | File:VitaminD5 structure.png |
Several forms (vitamers) of vitamin D have been discovered (see table). The two major forms are vitamin D2 or ergocalciferol, and vitamin D3 or cholecalciferol. These are known collectively as calciferol.[11] Vitamin D2 was chemically characterized in 1932. In 1936 the chemical structure of vitamin D3 was established and resulted from the ultraviolet irradiation of 7-dehydrocholesterol.[12]
Chemically, the various forms of vitamin D are secosteroids; i.e., steroids in which one of the bonds in the steroid rings is broken.[13] The structural difference between vitamin D2 and vitamin D3 is in their side chains. The side chain of D2 contains a double bond between carbons 22 and 23, and a methyl group on carbon 24.
Vitamin D2 (made from ergosterol) is produced by invertebrates, fungus and plants in response to UV irradiation; it is not produced by vertebrates. Little is known about the biologic function of vitamin D2 in nonvertebrate species. Because ergosterol can more efficiently absorb the ultraviolet radiation that can damage DNA, RNA and protein it has been suggested that ergosterol serves as a sunscreening system that protects organisms from damaging high energy ultraviolet radiation.[14]
Vitamin D3 is made in the skin when 7-dehydrocholesterol reacts with UVB ultraviolet light at wavelengths between 270–300 nm, with peak synthesis occurring between 295-297 nm.[15][16] These wavelengths are present in sunlight when the UV index is greater than 3. At this solar elevation, which occurs daily within the tropics, daily during the spring and summer seasons in temperate regions, and almost never within the arctic circles, vitamin D3 can be made in the skin, with prolonged exposure to UVB rays an equilibrium is achieved in the skin, and excess vitamin D simply degrades as fast as it is generated.[17]
Production in the skin
The skin consists of two primary layers: the inner layer called the dermis, composed largely of connective tissue, and the outer, thinner epidermis. The epidermis consists of five strata; from outer to inner they are: the stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale.
Cholecalciferol is produced photochemically in the skin from 7-dehydrocholesterol; 7-dehydrocholesterol is produced in relatively large quantities in the skin of most vertebrate animals, including humans.[18] The naked mole rat appears to be naturally cholecalciferol deficient as serum 25-OH vitamin D levels are undetectable[19] interestingly the naked mole rat is resistant to aging, maintains healthy vascular function[20]and is the longest lived of all rodents.[21][22]
In some animals, the presence of fur or feathers blocks the UV rays from reaching the skin. In birds and fur-bearing mammals, vitamin D is generated from the oily secretions of the skin deposited onto the fur and obtained orally during grooming.[23]
In 1923, it was established that when 7-dehydrocholesterol is irradiated with light, a form of a fat-soluble vitamin is produced. Alfred Fabian Hess showed that "light equals vitamin D".[24] Adolf Windaus, at the University of Göttingen in Germany, received the Nobel Prize in Chemistry in 1928, for his work on the constitution of sterols and their connection with vitamins.[25] In the 1930s he clarified further the chemical structure of vitamin D.
Synthesis mechanism (form 3)
7-dehydrocholesterol, a derivative of cholesterol, is photolyzed by ultraviolet light in 6-electron conrotatory electrocyclic reaction. The product is pre-vitamin D3. | |
Pre-vitamin D3 then spontaneously isomerizes to Vitamin D3 in a antarafacial hydride [1,7] Sigmatropic shift. At room temperature the transformation of previtamin-D3 to vitamin D3 takes about 12 days to complete.[14] | |
Whether it is made in the skin or ingested, vitamin D3 (cholecalciferol) is then hydroxylated in the liver to 25-hydroxycholecalciferol (25(OH)D3 or calcidiol) by the enzyme 25-hydroxylase produced by hepatocytes. This hydroxylation reaction occurs in the endoplasmic reticulum and requires NADPH, O2 and Mg2+ yet it is not a cytochrome P450 enzyme. Once made the product is stored in the hepatocytes until it is needed and then can be released into the plasma where it will be bound to an α-globulin.
25-hydroxycholecalciferol is then transported to the proximal tubules of the kidneys where it can be hydroxylated by one of two enzymes to different forms of vitamin D, one of which is active vitamin D (1,25-OH D) and another which is inactive vitamin D (24,25-OH D). The enzyme 1α-hydroxylase which is activated by parathyroid hormone (and additionally by low calcium or phosphate) forms the main biologically active vitamin D hormone with a C1 hydroxylation forming 1,25-dihydroxycholecalciferol (1,25(OH)2D3, also known as calcitriol). A separate enzyme hydroxylates the C24 atom forming 24R,25(OH)2D3 when 1α-hydroxylase is not active, this inactivates the molecule from any biological activity. Calcitriol is represented below right (hydroxylated Carbon 1 is on the lower ring at right, hydroxylated Carbon 25 is at the upper right end). |
Mechanism of action
After vitamin D is produced in the middle layers of skin or consumed in food, it is converted in the liver and kidney to form 1,25 dihydroxyvitamin D, (1,25(OH)2D), the physiologically active form of vitamin D (when "D" is used without a subscript it refers to either D2 or D3). This physiologically active form of vitamin D is known as calcitriol. Following this conversion, calcitriol is released into the circulation, and by binding to a carrier protein in the plasma, vitamin D-binding protein (VDBP), it is transported to various target organs.[13]
The physiologically active form of vitamin D mediates its biological effects by binding to the vitamin D receptor (VDR), which is principally located in the nuclei of target cells.[13] The binding of calcitriol to the VDR allows the VDR to act as a transcription factor that modulates the gene expression of transport proteins (such as TRPV6 and calbindin), which are involved in calcium absorption in the intestine.
The vitamin D receptor belongs to the nuclear receptor superfamily of steroid/thyroid hormone receptors, and VDRs are expressed by cells in most organs, including the brain, heart, skin, gonads, prostate, and breast. VDR activation in the intestine, bone, kidney, and parathyroid gland cells leads to the maintenance of calcium and phosphorus levels in the blood (with the assistance of parathyroid hormone and calcitonin) and to the maintenance of bone content.[26]
The VDR is known to be involved in cell proliferation and differentiation. Vitamin D also affects the immune system, and VDRs are expressed in several white blood cells, including monocytes and activated T and B cells.[27]
Apart from VDR activation, various alternative mechanisms of action are known. An important one of these is its role as a natural inhibitor of signal transduction by hedgehog (a hormone involved in morphogenesis).[28][29]
Nutrition
Vitamin D is naturally produced by the human body when exposed to direct sunlight. In many countries, such foods as milk, yogurt, margarine, oil spreads, breakfast cereal, pastries, and bread are fortified with vitamin D2 and/or vitamin D3.[30] In the United States and Canada, for example, fortified milk typically provides 100 IU per cup, or a quarter of the estimated adequate intake for adults over age 50.[2][31]
Natural sources
Natural sources of vitamin D include:[2]
- Fatty fish species, such as:
- Herring, 85 g (3 ounces (oz)) provides 1383 IU
- Catfish, 85 g (3 oz) provides 425 IU
- Salmon, cooked, 100 g (3.5 oz) provides 360 IU
- Mackerel, cooked, 100 g (3.5 oz), 345 IU
- Sardines, canned in oil, drained, 50 g (1.75 oz), 250 IU
- Tuna, canned in oil, 85 g (3 oz), 200 IU
- Eel, cooked, 100 g (3.5 oz), 200 IU
- Fish liver oils, such as cod liver oil, 1 Tbs. (15 ml) provides 1,360 IU (one IU equals 25 ng)
- A whole egg, provides 20 IU
- Beef liver, cooked, 100 g (3.5 oz), provides 15 IU
- Mushrooms (after UV light exposure)[32][33]
In the United States (U.S.), typical diets provide about 100 IU/day, the NIH has set the safe upper limit at 2000 IU/day.[34][35]
Measuring vitamin D status
A blood calcidiol (25-hydroxy-vitamin D) level is a satisfactory way to determine the cumulative effect of sun and diet in relation to vitamin D[36] although serum 25(OH)D levels do not indicate the amount of vitamin D stored in other body tissues.[37] A concentration of over 15 ng/ml (>37.5 nmol/L) is recommended. Higher levels (>30 ng/ml or >75 nmol/L) are proposed by some as desirable for achieving optimum health but there is not enough evidence to support them.[38][39][40][41] A study of highly sun exposed young people in Hawaii concluded that as the highest 25(OH)D concentration produced by natural UV exposure seems to be approximately 60 ng/ml (150nmol/L) this value ought to be seen as the upper limit when prescribing vitamin D supplementation.[42] In a multiethnic cohort there was an increased risk of prostate cancer for those with plasma 25-hydroxyvitamin D of 50ng/ml (125nmol/L)[43]
Deficiency
Low blood calcidiol (25-hydroxy-vitamin D) can result from avoiding the sun although deficiency may also exist in those with abundant exposure to bright sunlight.[44] Dietary intake supplies a modest amount of vitamin D as few foods contain a significant quantity of vitamin D relative to synthesis in the skin which can supply a large amount. Some genetic diseases have the appearance of rickets,[45][46][47] these are associated with consanguineous marriage.[48][49][50][51][52][53][54] and possibly founder effect.[55] In Kashmir, India patients with pseudovitamin D deficiency rickets had grossly raised 25-hydroxyvitamin D concentrations.[56] Skin colour has also been associated with low 25(OH)D, especially in Africans living in countries with a temperate climate. For example 25-OHD under 10ng/mL (25 nmol/l) in 44% of asymptomatic East African children living in Melbourne[57][58] However a study of healthy young Ethiopians living in Addis Ababa (10 degrees N) found average 25(OH)D levels of 23.5nmol/L.[59] A review of Vitamin D in Africa[60] gives the median levels for equatorial countries: Kenya 65.5 nmol/L and Zaire 65nmol/L, concluding that it remains to be established if associations between vitamin D status and health outcomes identified in Western countries can be replicated in African countries.
Vitamin D levels are approximately 30% higher in northern Europe than in central and southern Europe, higher vitamin D concentrations in northern countries may have a genetic basis.[61][62] In a meta-analysis of cross-sectional studies on serum 25(OH)D concentrations globally the levels averaged 54 nmol/l and were higher in women than men, and higher in Caucasians than in non-Caucasians. There was no trend in serum 25(OH)D level with latitude.[63] African Americans often have a very low circulating 25(OH)D level, however those of African descent have higher parathyroid hormone and 1,25-Dihydroxycholecalciferol associated with lower 25-hydroxyvitamin D than other ethnic groups, moreover they have the greatest bone density[64] and lowest risk of fragility fractures compared to other populations.[65][66][67] African American adults are less likely to be diagnosed with coronary heart disease,[68] in 2006, 9.4% of white men, 7.8% of black men, and 5.3% of Mexican American men had coronary heart disease,[69] the NHANES I Epidemiologic Follow-up Study concluded African-American men aged 25 to 74 years had lower age-adjusted rates of coronary heart disease and acute myocardial infarction than white men of the same ages,[70] African Americans have a lower prevalence and extent of coronary artery calcium (CAC) than whites.[71] The incidence of testicular cancer among African Americans was calculated to be one quarter of that among whites.[72] Frank deficiency of vitamin D can result from a number of hereditary disorders.[3] Deficiency results in impaired bone mineralization, and leads to bone softening diseases[73] including:
- Rickets, a childhood disease characterized by impeded growth, and deformity, of the long bones which can be caused by calcium or phosphorus deficiency as well as a lack of vitamin D, today it is largely found in low income counties in Africa, Asia or the Middle East.[74][75][76] Rickets was first described in the 17th century by Francis Glisson who stated in 1650 that it had first appeared about 30 years previously in the counties of Dorset and Somerset.[77] In 1857 John Snow (physician) suggested the rickets then widespread in Britain was being caused by the adulteration of bakers bread with alum.[78] The role of diet in the development of rickets[79][80] was determined by Edward Mellanby between 1918–1920.[81] By altering the diets of dogs raised in the absence of sunlight, he was able to establish unequivocally that rickets was linked with diet, and identified cod liver oil as an excellent anti-rachitic agent and phytic acid as a rachitic agent.[82][83][84] Nutritional rickets exists in countries with intense year round sunlight such as Nigeria and can occur without vitamin D deficiency.[85][86] In 1921 Elmer McCollum identified a substance found in certain fats that could prevent rickets. Prior to the fortification of milk products with vitamin D, rickets was a major public health problem, in Denver where ultraviolet rays are approximately 20% stronger than at sea level on the same latitude[87] almost two thirds of 500 children had mild rickets in the late 1920's.[88] An increase in the amount of animal protein[89] in the 20th century American diet coupled with consumption of milk[90][91] fortified with relatively small quantities of vitamin D led to a dramatic decline in the number of rickets cases.[26] Although rickets is now rare in Britain there have been outbreaks in some immigrant communities but[92] the sufferers did not conform to the stereotype of concealing clothing. Having darker skin and reduced exposure to sunshine did not produce rickets unless the diet deviated from a Western omnivore pattern characterized by high intakes of meat, fish and eggs, and low intakes of high-extraction cereals.[93] The dietary risk factors for rickets are independent of the low vitamin D content of most foods and appear to result from interactions between constituents of animal foods and the intermediary metabolism of endogenously-synthesized vitamin D.[94]
- Osteomalacia, a bone-thinning disorder that occurs exclusively in adults and is characterized by proximal muscle weakness and bone fragility. The effects of osteomalacia are thought to contribute to chronic musculoskeletal pain.[95][96] but of the five small double-blind randomized controlled trials, only one found a reduction in pain after supplementation, and there is no persuasive evidence of lower vitamin D status in chronic pain sufferers compared to controls.[97]
There are associations between low 25(OH)D levels and many diseases,[98]including several autoimmune diseases.[10][26][99] However such associations were found in observational studies and are not conclusive evidence of a causal link, (see correlation does not imply causation), a systemic review[100] found no significant effect of vitamin D supplements.
One leading[101] proponent of the view that the optimal concentration of 25(OH)D is at least 30 ng/ml[102] defines vitamin D deficiency as a 25(OH)D level of under 20 ng/ml (50 nmol/l), applying this criterion he regards 30% to 50% of the United States population as suffering from vitamin D deficiency.[103] This includes areas with abundant sun exposure, such as Hawaii and southern Arizona where over 50% of inhabitants have 25(OH)D level of under 20 ng/ml.[104][105] Such metrics[106] depart from more typical definitions of vitamin deficiency which are based on prevention of overt deficiency symptoms or comparable biologic indicators.[107][108]
Overdose by ingestion
In healthy adults, sustained intake of 1250 micrograms/day (50,000 IU) can produce overt toxicity within months,[109] those with certain medical conditions are far more sensitive to vitamin D and develop hypercalcaemia in response to any increase in vitamin D nutrition while maternal hypercalcaemia during pregnancy may increase foetal sensitivity to effects of vitamin D and lead to a syndrome of mental retardation and facial deformities.[110][111] If you have a medical condition, are pregnant or think you may be, or are breastfeeding, you must consult your doctor before taking a vitamin D supplement. For infants (birth to 12 months) the tolerable Upper Limit, (maximum amount that can be tolerated without harm) is set at 25 micrograms/day (1000 IU). 1000 micrograms/day (40,000 IU) in infants has produced toxicity within 1 month.[3] The U.S. Dietary Reference Intake Tolerable Upper Intake Level (upper limit) of vitamin D for children and adults is set at 50 micrograms/day (2,000 IU). Serum levels of calcidiol (25-hydroxy-vitamin D) are typically used to diagnose vitamin D overdose which is known to cause hypercalcemia (an elevated level of calcium in the blood) caused by increased intestinal calcium absorption. Vitamin D toxicity is known to be a cause of high blood pressure.[112] anorexia, nausea, and vomiting. These symptoms are often followed by polyuria (excessive production of urine), polydipsia (increased thirst), weakness, nervousness, pruritus (itch), and eventually renal failure. Other signals of kidney disease including elevated protein levels in the urine, urinary casts, and a build up of wastes in the blood stream can also develop.[3] In one study, hypercalciuria and bone loss occurred in four patients with documented vitamin D toxicity.[113] Vitamin D toxicity is treated by discontinuing vitamin D supplementation, and restricting calcium intake. If the toxicity is severe blood calcium levels can be further reduced with corticosteroids or bisphosphonates. Kidney damage may be irreversible.
Exposure to sunlight for extended periods of time does not normally cause vitamin D toxicity.[114] This is because within about 20 minutes of ultraviolet exposure in light skinned individuals (3–6 times longer for pigmented skin) the concentration of vitamin D precursors produced in the skin reach an equilibrium, and any further vitamin D that is produced is degraded.[17] According to some sources, endogenous production with full body exposure to sunlight is approximately 250 µg (10,000 IU) per day.[114] According to Holick, "the skin has a large capacity to produce cholecalciferol"; his experiments indicate that,
"[W]hole-body exposure to one minimal erythemal dose of simulated solar ultraviolet radiation is comparable with taking an oral dose of between 250 and 625 micrograms (10 000 and 25 000 IU) vitamin D."[17]
It is on the basis of the supposedly similar effect of supplementation and whole body exposure to one erythemal dose that a leading researcher [115] has suggested that 250 micrograms/day (10,000 IU) in healthy adults should be adopted as the tolerable upper limit.[115] Supplements and skin synthesis have a different effect on on serum 25(OH)D concentrations;[116] endogenously synthesized vitamin D3 travels in plasma almost exclusively on vitamin D-binding protein (VDBP), providing for a slower hepatic delivery of the vitamin D and the more sustained increase in plasma 25-hydroxycholecalciferol observed after depot, parenteral administration of vitamin D. Yet the orally administered route vitamin D produces swift hepatic delivery of vitamin D, and transient, but nonetheless abrupt, increases in plasma 25-hydroxycholecalciferol. The richest food source of vitamin D — wild salmon — would require 35 ounces a day to provide 10,000IU.[117] It has been argued[118] that ingestion of vitamin D in large amounts was achieved in the process of grooming by furry human ancestors and that from UV-exposed human skin secretions early humans ingested vitamin D by licking the skin, however this putative ingestion of vitamin D by early humans is not quantified. A study[119] found 34% of its sample of healthy western Canadians to be be under 40nmol/L at some point and 97% to be under 80nmol/L at least once. It has been questioned.[120] whether to ascribe a state of sub-optimal vitamin D status when the annual variation in ultraviolet will naturally produce a period of falling levels, and such a seasonal decline has been a part of Europeans' adaptive environment[121] for 1000 generations,[122] is clear thinking.
Still more contentious is recommending supplementation when those supposedly in need of it are labeled healthy and serious doubts exist as to the long term effect of attaining and maintaining serum 25(OH)D of at least 80nmol/L by supplementation.[123] Possible ethnic differences in physiological pathways for ingested vitamin D, such as Inuit have, may confound across the board recommendations for vitamin D levels. Inuit compensate for lower production of vitamin D by converting more of this vitamin to its most active form[124] Another study by the Toronto group[125] did have 'young Canadian adults of diverse ancestry ' but applied a standard of serum 25(OH)D levels that was significantly higher than official recommedations.[126][127], 75 nmol/L as "optimal", between 75 nmol/L and 50 nmol/L as "insufficient" and < 50 nmol/L as "deficient". The results were ' 22% of individuals of European ancestry had 25(OH)D levels less than the 40 nmol/L cutoff, which is comparable to the values observed in previous studies. 78% of individuals of East Asian ancestry and 77% of individuals of South Asian ancestry had 25(OH)D concentrations lower than 40 nmol/L. The East Asians in the Toronto sample had low 25(OH)D levels when compared to whites. Lipps (2010)[128] in a world wide review says 'vitamin D deficiency (serum 25(OH)D<25nmol/l) is highly prevalent in China: "A survey in Beijing indicated that Vitamin D-deficiency (plasma 25(OH)D concentration <12.5 nmol/l) occurred in more than 40% of adolescent girls in winter." In a Chinese population at particular risk for esophageal cancer, those with the highest serum 25(OH)D concentrations have a significantly increased risk of the precursor lesion.[129] Inuit have relatively high rates of esophageal cancer and there are ethnic differences in the metabolism of vitamin D between Caucasians and Inuit.[130][131]
In South Asians Harinarayan (2009[132] found "All studies uniformly point to low 25(OH)D levels in the populations studies despite abundant sunshine in our country". For example rural men around Delhi average 44nmol/L. Healthy Indians living at the latitude they are presumably best adapted to seem have low 25(OH)D levels which are not very different from healthy South Asians living in Canada. South Indian patients with ischemic heart disease have serum 25-hydroxyvitamin D3 levels which are extremely high — above 222.5 nmol/l.[133] The Toronto group conclude -"skin pigmentation, assessed by measuring skin melanin content, showed an inverse relationship with serum 25(OH)D". The uniform occurence of very low serum 25(OH)D in Indians living in India and Chinese in China does not support the hypothesis that the low levels seen in the more pigmented are due to lack of synthesis from the sun at higher latitudes, the leader of the study has urged dark-skinned immigrants to take vitamin D supplements nonetheless; "I see no risk, no downside, there's only a potential benefit".[134][135] A study of French Canadians[136] found that a significant minority did not maximize ingested serum 25(OH)D for genetic reasons; vitamin D-binding protein polymorphisms explained as much of the variation in circulating 25(OH)D as did total ingestion of vitamin D.[137] Oral vitamin D intake,[138] is lower in Europe than both North America and Scandinavia.[139] Whether the toxicity of oral intake of vitamin D is due to that route being unnatural as suggested by Fraser.[140][141] is not known, but there is a certain amount of evidence to suggest that dietary vitamin D may be carried by lipoprotein particles[142] into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages.[143] These findings raise questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk. Dietary vitamin D may be causing vascular[144] calcification.
Health effects
Immune system
The hormonally active form of vitamin D mediates immunological effects by binding to nuclear vitamin D receptors (VDR).[145] VDR ligands have been shown to increase the activity of natural killer cells, and enhance the phagocytic activity of macrophages.[27] Active vitamin D hormone also increases the production of cathelicidin, an antimicrobial peptide that is produced in macrophages triggered by bacteria, viruses, and fungi.[146][147][148]
A 2006 study published in the Journal of the American Medical Association, reported evidence of a link between Vitamin D deficiency and the onset of multiple sclerosis; the authors posit that this is due to the immune-response suppression properties of Vitamin D.[149] Further research conducted in 2009 indicates that vitamin D is required to activate a histocompatibility gene (HLA-DRB1*1501) necessary for differentiating between self and foreign proteins in a subgroup of individuals genetically predisposed to MS.[150] It has been suggested that pregnant women take vitamin D during their pregnancy, to lessen the likelihood of the child developing MS later in life.[151][152] However vitamin D fortification has been suggested to have caused a pandemic of allergic disease,[153] a study of infants who received supplemental vitamin D found an association between vitamin D supplementation in infancy and an increased risk of atopy and allergic rhinitis later in life.[154] A 2010 study by veteran vitamin D researcher Hector DeLuca has cast doubt on whether the vitamin D sythesizing effect of UVB is the feature of sunlight that affects MS.[155] Ultraviolet- A radiation (which is not involved in synthesis of vitamin D) is known to affect the immune system.[156][157][158]
Influenza
In the 1918 flu pandemic most of the fatalities were healthy young adults and the outbreak was widespread in the summer and autumn (in the Northern Hemisphere). Neither of these facts suggest high vitamin D levels gave any protection, they are actually suggestive of increased mortality for those with higher 25(OH) D concentrations.
Cancer
The molecular basis for thinking vitamin D has the potential to prevent cancer lies in its role as a nuclear transcription factor that regulates cell growth, differentiation, apoptosis and a wide range of cellular mechanisms central to the development of cancer.[159] These effects may be mediated through vitamin D receptors expressed in cancer cells.[27]
A 2005 metastudy found correlations between vitamin D levels and and cancer. Drawing from a meta-analysis of 63 observational studies of vitamin D status , the authors suggested that intake of an additional 1,000 international units (IU) (or 25 micrograms) of vitamin D daily reduced an individual's colon cancer risk by 50%, and breast and ovarian cancer risks by 30%.[160][161][162][163]
A 2006 study using data on over 4 million cancer patients from 13 different countries showed a marked difference in cancer risk between countries classified as sunny and countries classified as less–sunny for a number of different cancers, it has been disputed whether the predictive models used in such studies are accurate in estimating 25(OH)D levels[164][165] Research has also suggested that cancer patients who have surgery or treatment in the summer — and therefore make more endogenous vitamin D — have a better chance of surviving their cancer than those who undergo treatment in the winter when they are exposed to less sunlight.[166] However vitamin D levels do not depend on regional solar irradiance[167] Another 2006 study found that taking the U.S. RDA of vitamin D (400 IU per day) cut the risk of pancreatic cancer by 43% in a sample of more than 120,000 people from two long-term health surveys.[168][169] However in male smokers a 3-fold increased risk for pancreatic cancer in the highest compared to lowest quintile of serum 25-hydroxyvitamin D concentration has been found.[170] Research is being done on the use of calcitriol in the medical treatment of patients with advanced prostate cancer.[171]
Polymorphisms of the vitamin D receptor (VDR) gene have been associated with an increased risk of breast cancer.[172] Impairment of the VDR-mediated gene expression is thought to alter mammary gland development or function and may predispose cells to malignant transformation. Women with homozygous FOK1 mutations in the VDR gene had an increased risk of breast cancer compared with the women who did not. FOK1 mutation has also been associated with decreasing bone mineral density which in turn may be associated with an increase in the risk of breast cancer.[173]While low levels of vitamin D in serum have been correlated with breast cancer disease progression and bone metastases[172] and studies suggest that increased intake of vitamin D reduces the risk of breast cancer in premenopausal women,[174]other studies found no effect on breast or colorectal cancers.[175][176]
A randomized intervention study involving 1,200 women, published in June 2007, reports that vitamin D supplementation (1,100 international units (IU)/day) resulted in a 60% reduction in cancer incidence, during a four-year clinical trial, rising to a 77% reduction for cancers diagnosed after the first year (and therefore excluding those cancers more likely to have originated prior to the vitamin D intervention).[177][178] Although the study was criticized on several grounds[179] including failing to take into account a long term overall increase in cancer found in a another study of vitamin D intake[180] in 2007 the Canadian Cancer Society, (a national community-based organization of volunteers) recommended that all adults begin taking 1,000 IU per day (five times more than the government says they need) .[181][182] A US National Cancer Institute study analyzed data from the third national Health and Nutrition Examination Survey to examine the relationship between levels of circulating vitamin D in the blood and cancer mortality in a group of 16,818 participants aged 17 and older. It found no support for an association between 25(OH)D and total cancer mortality,[183] unlike other studies it was done prospectively – meaning that participants were followed looking forward, and actual blood tests were used to measure the amount of vitamin D in their blood rather than than by trying to infer vitamin D levels from predictive models which may be inaccurate.[184][185][186]
Cardiovascular disease
There is a certain amount of evidence to suggest that dietary vitamin D may be carried by lipoprotein particles[187] into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages.[188] These findings raise questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk. Dietary vitamin D may be causing vascular[189] calcification. Low levels of vitamin D are associated with an increase in high blood pressure and cardiovascular risk. Numerous observational studies show this link, but of two systemic reviews one found only weak evidence of benefit from supplements and the other found no evidence of a beneficial effect whatsoever.[190][191][192] The precise mechanism for cardiovascular regulation is still under investigation; possibilities include blood pressure regulation through the renin-angiotensin system, parathyroid hormone levels, direct impact on heart muscle function, inflammation, and vascular calcification.[193]
When researchers monitored the vitamin D levels, blood pressure and other cardiovascular risk factors of 1739 people, of an average age of 59 years for 5 years, they found that those people with low levels of vitamin D had a 62% higher risk of a cardiovascular event than those with normal vitamin D levels.[194] Low levels of vitamin D have also been correlated with hypertension, elevated VLDL triglycerides, and impaired insulin metabolism.[195]
A report from the National Health and Nutrition Examination Survey (NHANES) involving nearly 5,000 participants found that low levels of vitamin D were associated with an increased risk of peripheral artery disease (PAD). The incidence of PAD was 80% higher in participants with the lowest vitamin D levels (<17.8 ng/mL).[98] Cholesterol levels were found to be reduced in gardeners in the UK during the summer months.[196] Heart attacks peak in winter and decline in summer in temperate[197] but not tropical latitudes.[198] Calcifediol (25-hydroxy-vitamin D) is implicated in the etiology of atherosclerosis, especially in non-Caucasians.[140][199][133][200] Vitamin D levels are generally higher in the physically fit but are lower in those of tropical origin, this is a confound for any attempt to make a worldwide recommendation for vitamin D.[201] 1,25-Dihydroxycholecalciferol(active serum vitamin D) levels are inversely correlated with coronary calcification[202] moreover one-alpha-hydroxy-cholecalciferol, an active vitamin D analog[203] therapy seems to protect patients from developing vascular calcification.[204] African Americans have higher active serum vitamin D levels.[205][206][207] There are racial differences in the association of coronary calcified plaque[208] in that there is less calcified atherosclerotic plaque in the coronary arteries of African-Americans than in whites. One study found an elevated risk of ischaemic heart disease in Southern India in individuals whose vitamin D levels were above 89 ng/mL.[133] Freedman et al. (2010) have found that serum vitamin D correlates in African Americans, but not in Euro-Americans, with calcified atheroscleratic plaque. Pharmacokinetics of vitamin D toxicity states - "Early assumptions that 1,25(OH)2D3 might cause hypercalcemia in vitamin D toxicity have been replaced by the theories that 25(OH)D3 at pharmacologic concentrations can overcome vitamin D receptor affinity disadvantages to directly stimulate transcription or that total vitamin D metabolite concentrations displace 1,25(OH)2D from vitamin D binding".[37] Freedman et al. (2010) states - "Higher levels of 25-hydroxyvitamin D seem to be positively correlated with aorta and carotid CP in African Americans but not with coronary CP. These results contradict what is observed in individuals of European descent".[209] Recommendations stemming for a single standard for optimal serum 25(OH)D concentrations ignores the differing genetically mediated determinates of serum 25(OH)D and may result in ethnic minorities in Western countries having the results of studies done with subjects not representative of ethnic diversity applied to them. Vitamin D levels vary for genetically mediated reasons as well as environmental ones.[210][211][212][62][213][214][215][208][216] Among descent groups with heavy sun exposure during their evolution, taking supplemental vitamin D to attain the 25(OH)D level associated with optimal health in studies done with mainly European populations may have deleterious outcomes.[217] A review of vitamin D status in India concluded that studies uniformly point to low 25(OH)D levels in Indians despite abundant sunshine, and suggested a public health need to fortify Indian foods with vitamin D might exist. However the levels found in India are consistent with many other studies of tropical populations which have found that even an extreme amount of sun exposure, such as incured by rural Indians,[218] does not raise 25(OH)D levels to the levels typically found in Europeans,[219][220][221][222][223][224][225]
Mortality
Using information from the National Health and Nutrition Examination Survey a group of researchers concluded that having low levels of vitamin D (<17.8 ng/ml) was independently associated with an increase in all-cause mortality in the general population.[226] The study evaluated whether low serum vitamin D levels were associated with all-cause mortality, cancer, and cardiovascular disease (CVD) mortality among 13,331 diverse American adults who were 20 years or older. Vitamin D levels of these participants were collected over a 6-year period (from 1988 through 1994), and individuals were passively followed for mortality through the year 2000. Shortening of leukocyte telomeres is a marker of aging. Leukocyte telomere length (LTL) predicts the development of aging-related disease, and length of these telomeres decreases with each cell division and with increased inflammation (more common in the elderly). Vitamin D can inhibit proinflammatory overeaction and slow the turnover of leukocytes, longer leukocyte telomere length is achieved by the body maintaining the optimal vitamin D concentration.[227]
Complex regulatory mechanisms control metabolism, recent epidemiologic evidence suggests that there is a narrow range of vitamin D levels in which vascular function is optimized. Levels above or below this natural homeostasis of vitamin D increase mortality.[228] Overall, excess or deficiency in the calcipherol system appear to cause abnormal functioning and premature aging.[229][230][231]
See also
- Marshall Protocol
- Mushrooms and Vitamin D
- Risks and benefits of sun exposure
- Vitamin D and influenza
References
- ^ Walter F., PhD. Boron (2003). "The Parathyroid Glands and Vitamin F". Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders. p. 1094. ISBN 978-1-4160-2328-9.
- ^ a b c "Dietary Supplement Fact Sheet: Vitamin D". National Institutes of Health. Archived from the original on 2007-09-10. Retrieved 2007-09-10.
- ^ a b c d Vitamin D at The Merck Manual of Diagnosis and Therapy Professional Edition
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9023488, please use {{cite journal}} with
|pmid=9023488
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18088161, please use {{cite journal}} with
|pmid=18088161
instead. - ^ Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D Position Statement by the Scientific Advisory Committee on Nutrition 2007 ISBN 9780112431145
- ^ Office of Dietary Supplements • National Institutes of Health Dietary Supplement Fact Sheet: Vitamin D [1]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 3858880, please use {{cite journal}} with
|pmid=3858880
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 3771798, please use {{cite journal}} with
|pmid=3771798
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17990825, please use {{cite journal}} with
|pmid=17990825
instead. - ^ Dorland's Illustrated Medical Dictionary, under Vitamin (Table of Vitamins)
- ^ History of Vitamin D University of California, Riverside, Vitamin D Workshop.
- ^ a b c About Vitamin D Including Sections: History, Nutrition, Chemistry, Biochemistry, and Diseases. University of California Riverside
- ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 14985208, please use {{cite journal}} with
|pmid=14985208
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9625080, please use {{cite journal}} with
|pmid=9625080
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6281884, please use {{cite journal}} with
|pmid=6281884
instead. - ^ a b c Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 7879731, please use {{cite journal}} with
|pmid=7879731
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12514284, please use {{cite journal}} with
|pmid=12514284
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8384476, please use {{cite journal}} with
|pmid=8384476
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17468332, please use {{cite journal}} with
|pmid=17468332
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18180931, please use {{cite journal}} with
|pmid=18180931
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18180931, please use {{cite journal}} with
|pmid=18180931
instead. - ^ Sam D. Stout; Sabrina C. Agarwal; Stout, Samuel D. (2003). Bone loss and osteoporosis: an anthropological perspective. New York: Kluwer Academic/Plenum Publishers. ISBN 0-306-47767-X.
{{cite book}}
: CS1 maint: multiple names: authors list (link) - ^ UNRAVELING THE ENIGMA OF VITAMIN D U.S. National Academy of Sciences
- ^ Windaus biography at nobelprize.org
- ^ a b c Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15585788, please use {{cite journal}} with
|pmid=15585788
instead. - ^ a b c Vitamin D The Physicians Desk Reference. 2006 Thompson Healthcare.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16895439, please use {{cite journal}} with
|pmid=16895439
instead. - ^ http://www.medscape.com/viewarticle/713649_3 Hedgehog signaling and Vitamin D
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12149085, please use {{cite journal}} with
|pmid=12149085
instead. - ^ Holick, Michael (2007). The Vitamin D Pandemic and its Health Consequences. 34th European Symposium on Calcified Tissues. Copenhagen.
{{cite conference}}
: Unknown parameter|month=
ignored (help) - ^ http://articles.latimes.com/2008/mar/31/health/he-eat31
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19281276, please use {{cite journal}} with
|pmid=19281276
instead. - ^ Dietary Supplement Fact Sheet: Vitamin D
- ^ Dietary Reference Intakes for Vitamin D and Calcium
- ^ Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride(1997)., ISBN 978-0-309-06350-0. [2] page 235[3]
- ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18689406, please use {{cite journal}} with
|pmid=18689406
instead. - ^ Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D Position Statement by the Scientific Advisory Committee on Nutrition 2007 ISBN 9780112431145
- ^ Office of Dietary Supplements • National Institutes of Health Dietary Supplement Fact Sheet: Vitamin D [4]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20194237, please use {{cite journal}} with
|pmid=20194237
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20194238, please use {{cite journal}} with
|pmid=20194238
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17426097, please use {{cite journal}} with
|pmid=17426097
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20064705, please use {{cite journal}} with
|pmid=20064705
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18234141, please use {{cite journal}} with
|pmid=18234141
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9333115, please use {{cite journal}} with
|pmid=9333115
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12674324, please use {{cite journal}} with
|pmid=12674324
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 4542997, please use {{cite journal}} with
|pmid=4542997
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 681423, please use {{cite journal}} with
|pmid=681423
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 180907, please use {{cite journal}} with
|pmid=180907
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 4377866, please use {{cite journal}} with
|pmid=4377866
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9486994, please use {{cite journal}} with
|pmid=9486994
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1097/BCO.0b013e3282b97118, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1097/BCO.0b013e3282b97118
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.bone.2009.09.016, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/j.bone.2009.09.016
instead. - ^ Vitamin D and rickets By Z. Hochberg
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8751865, please use {{cite journal}} with
|pmid=8751865
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1136/pmj.76.896.369, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1136/pmj.76.896.369
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17492073, please use {{cite journal}} with
|pmid=17492073
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1136/adc.2006.112813, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1136/adc.2006.112813
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 10526248, please use {{cite journal}} with
|pmid=10526248
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1007/s12018-009-9038-6, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1007/s12018-009-9038-6
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19915719, please use {{cite journal}} with
|pmid=19915719
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17287117, please use {{cite journal}} with
|pmid=17287117
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1007/s00198-008-0626-y, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1007/s00198-008-0626-y
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12107201, please use {{cite journal}} with
|pmid= 12107201
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16549493, please use {{cite journal}} with
|pmid=16549493
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.2215/CJN.06361208, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.2215/CJN.06361208
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18689399, please use {{cite journal}} with
|pmid=18689399
instead. - ^ Office of Minority Health[5]
- ^ Dept. Of Health and Human Services [6]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9229999, please use {{cite journal}} with
|pmid=9229999
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.jcct.2008.12.009, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/j.jcct.2008.12.009
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16140086, please use {{cite journal}} with
|pmid=16140086
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15989379, please use {{cite journal}} with
|pmid=15989379
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17943890, please use {{cite journal}} with
|pmid=17943890
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18214537, please use {{cite journal}} with
|pmid=18214537
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15585795, please use {{cite journal}} with
|pmid=15585795
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 7503834, please use {{cite journal}} with
|pmid=7503834
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12777415, please use {{cite journal}} with
|pmid=12777415
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/0003-9861(55)90106-5, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/0003-9861(55)90106-5
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 5069221, please use {{cite journal}} with
|pmid=5069221
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12897318, please use {{cite journal}} with
|pmid=12897318
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16747083, please use {{cite journal}} with
|pmid=16747083
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15395027, please use {{cite journal}} with
|pmid=15395027
instead. - ^ History of Vitamin D University of California, Riverside, Vitamin D Workshop.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18197991, please use {{cite journal}} with
|pmid=18197991
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 10584471, please use {{cite journal}} with
|pmid=10584471
instead. - ^ US National Institutes Of Health, National cancer Institute[7]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 4862158, please use {{cite journal}} with
|pmid=4862158
instead. - ^ Garrison, R., Jr., Somer, E., The nutrition desk reference(1997)
- ^ E. Melanie DuPuis., Nature's Perfect Food: How Milk Became America's Drink(2002) ISBN 978-0814719381
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 10232644, please use {{cite journal}} with
|pmid=10232644
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1136/bmj.291.6490.239, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1136/bmj.291.6490.239
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6970590, please use {{cite journal}} with
|pmid=6970590
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9483661, please use {{cite journal}} with
|pmid=9483661
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12520530, please use {{cite journal}} with
|pmid=12520530
instead. - ^ Stewart B. Leavitt. "Vitamin D – A Neglected 'Analgesic' for Chronic Musculoskeletal Pain" (PDF). Pain-Topics.org. Retrieved 2009-03-25.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19084336, please use {{cite journal}} with
|pmid=19084336
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18417640, please use {{cite journal}} with
|pmid=18417640
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18852350, please use {{cite journal}} with
|pmid=18852350
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20194237, please use {{cite journal}} with
|pmid=20194237
instead. - ^ Holick., M., The Vitamin D Solution: A 3- Step Strategy to Cure Our Most Common Health Problem (2010) ISBN 1594630674
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.jacc.2008.08.050, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/j.jacc.2008.08.050
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.jacc.2009.02.031, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/j.jacc.2009.02.031
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18326598, please use {{cite journal}} with
|pmid=18326598
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1210/jc.2006-2250, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1210/jc.2006-2250
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16825677, please use {{cite journal}} with
|pmid=16825677
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.jacc.2008.12.070, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/j.jacc.2008.12.070
instead. - ^ Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride(1997)., ISBN 978-0-309-06350-0. [8] page 235[9]
- ^ Vitamin D. The Merck Manuals Vitamin D [10]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 10232622, please use {{cite journal}} with
|pmid=10232622
instead. - ^ [11]European Food and Safety authority., Tolerable Upper Intake Limits for Vitamins And Minerals(2006) ISBN 92-9199-014-0
- ^ "Complete Guide to Vitamins, Minerals and Supplements", Fisher Books, Tucsan AZ, 1988, p42
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9245225, please use {{cite journal}} with
|pmid=9245225
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 10232622, please use {{cite journal}} with
|pmid=10232622
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17209171, please use {{cite journal}} with
|pmid=17209171
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1172/JCI116492, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1172/JCI116492
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17267210, please use {{cite journal}} with
|pmid=17267210
instead. - ^ [Effects Of Vitamin D and the Natural selection of skin colour:how much vitamin D nutrition are we talking about http://www.direct-ms.org/pdf/VitDVieth/Vieth%20Anthropology%20vit%20D.pdf]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17855710, please use {{cite journal}} with
|pmid=17855710
instead. - ^ [Tseng, Lisa. (2003). Controversies in Vitamin D Supplementation. Nutrition Bytes, 9(1) http://escholarship.org/uc/item/4m84d4fn] (Peer reviewed)
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1186/1471-2458-9-22, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1186/1471-2458-9-22
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1073/pnas.0903446106, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1073/pnas.0903446106
instead. - ^ [Tseng, Lisa. (2003). Controversies in Vitamin D Supplementation. Nutrition Bytes, 9(1) http://escholarship.org/uc/item/4m84d4fn]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 14708040, please use {{cite journal}} with
|pmid=14708040
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1186/1471-2458-8-336, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1186/1471-2458-8-336
instead. - ^ Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D Position Statement by the Scientific Advisory Committee on Nutrition 2007 ISBN 9780112431145
- ^ Office of Dietary Supplements • National Institutes of Health Dietary Supplement Fact Sheet: Vitamin D [12]
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20197091, please use {{cite journal}} with
|pmid= 20197091
instead., - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17855710, please use {{cite journal}} with
|pmid= 17855710
instead., - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 14708040, please use {{cite journal}} with
|pmid=14708040
instead., - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18760245, please use {{cite journal}} with
|pmid=18760245
instead., - ^ Harinarayan Vitamin D Status in India – Its Implications and Remedial Measures (2009) [cite http://www.japi.org/january_2009/R-1.html]a review of over 50 studies of 25(OH)D
- ^ a b c Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 11949730, please use {{cite journal}} with
|pmid=11949730
instead. - ^ CBC Dark-skinned immigrants urged to take vitamin DTuesday, February 16, 2010 CBC news
- ^ STEPHEN STRAUSS: SCIENCE FRICTION The vitamin D debate Feb. 13, 2008 [13] CBC Analysis and viewpoint
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.3945/ajcn.2008.26445, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.3945/ajcn.2008.26445
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8751865, please use {{cite journal}} with
|pmid=8751865
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 1385673, please use {{cite journal}} with
|pmid=1385673
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8390483, please use {{cite journal}} with
|pmid=8390483
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6132277, please use {{cite journal}} with
|pmid=6132277
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8390483, please use {{cite journal}} with
|pmid=8390483
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1258/acb.2009.009018, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1258/acb.2009.009018
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.2215/CJN.01220308, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.2215/CJN.01220308
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18519861, please use {{cite journal}} with
|pmid=18519861
instead., - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15798098, please use {{cite journal}} with
|pmid=15798098
instead. - ^ Janet Raloff, The Antibiotic Vitamin Science News, Vol 170, November 11, 2006, pages 312-317
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17463418, please use {{cite journal}} with
|pmid=17463418
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9269215, please use {{cite journal}} with
|pmid=9269215
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17179460, please use {{cite journal}} with
|pmid=17179460
instead. - ^ "Science News / Molecular Link Between Vitamin D Deficiency And MS". Retrieved 2009-02-25.
- ^ Vitamin D helps control MS gene. BBC News. 5 February 2009.
- ^ Genetic Study Supports Vitamin D Deficiency as an Environmental Factor in MS Susceptibility. Multiple Sclerosis Society of Canada. 5 February 2009
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20016691, please use {{cite journal}} with
|pmid=20016691
instead., - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15699498, please use {{cite journal}} with
|pmid=15699498
instead., - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1073/pnas.1001119107, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1073/pnas.1001119107
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1039/b9pp00051h, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1039/b9pp00051h
instead.. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1111/j.1751-1097.2007.00184.x, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1111/j.1751-1097.2007.00184.x
instead.. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1038/jid.2009.121, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1038/jid.2009.121
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18034918, please use {{cite journal}} with
|pmid=18034918
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16380576, please use {{cite journal}} with
|pmid=16380576
instead. - ^ "Vitamin D 'can lower cancer risk'". BBC News. 28 December 2005. Retrieved 2006-03-23.
- ^ Gorham ED, Garland CF, Garland FC et al. (2007). "Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 32:210-216.
- ^ Garland CF, Mohr SB, Gorham ED et al. (2006). "Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer." Am J Prev Med. 31:512-514.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20219959, please use {{cite journal}} with
|pmid=20219959
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17540555, please use {{cite journal}} with
|pmid=17540555
instead. - ^ "Vitamin D 'aids lung cancer ops'". BBC News. 22 April 2005. Retrieved 2006-03-23.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20219959, please use {{cite journal}} with
|pmid=20219959
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16985031, please use {{cite journal}} with
|pmid=16985031
instead. - ^ BBC NEWS | Health | Vitamin D 'slashes cancer risk'
- ^ doi:10.1158/0008-5472.CAN-06-1876
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16886675, please use {{cite journal}} with
|pmid=16886675
instead. - ^ a b Buyru N, Tezol A;,Yosunkaya-Fenerci E, Dalay, N. Vitamin D receptor gene polymorphisms in breast cancer. Experimental and Molecular Medicine. 2003; 35(6):550-555.
- ^ Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk. Cancer Epidemiology, Biomarkers, & Prevention. 2005; 14(10):2335-2339.
- ^ Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Archives of Internal Medicine.2007; 167(10):1050-9,
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1093/jnci/djn360, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1093/jnci/djn360
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16467233, please use {{cite journal}} with
|pmid= 16467233
instead., - ^ Martin Mittelstaedt (28 April 2007). "Vitamin D casts cancer prevention in new light". Global and Mail. Retrieved 2007-04-28.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17556697, please use {{cite journal}} with
|pmid=17556697
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18065602, please use {{cite journal}} with
|pmid=18065602
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17549593, please use {{cite journal}} with
|pmid=17549593
instead. - ^ Canadian Cancer Society announces Vitamin D recommendation, 08 June 2007.
- ^ Canadian Cancer Society recommends vitamin D. CTV.ca News Staff
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17971526, please use {{cite journal}} with
|pmid=17971526
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1093/jnci/djm235, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1093/jnci/djm235
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20219959, please use {{cite journal}} with
|pmid=20219959
instead. - ^ Maybe Vitamin D Isn't The Answer After All[14]
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1258/acb.2009.009018, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1258/acb.2009.009018
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.2215/CJN.01220308, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.2215/CJN.01220308
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18519861, please use {{cite journal}} with
|pmid=18519861
instead., - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20194237, please use {{cite journal}} with
|pmid=20194237
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20194238, please use {{cite journal}} with
|pmid=20194238
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19476421, please use {{cite journal}} with
|pmid=19476421
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19852887, please use {{cite journal}} with
|pmid=19852887
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18180395, please use {{cite journal}} with
|pmid=18180395
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8541004, please use {{cite journal}} with
|pmid=8541004
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8935479, please use {{cite journal}} with
|pmid=8935479
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9581712, please use {{cite journal}} with
|pmid=9581712
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/S0735-1097(98)00098-9, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/S0735-1097(98)00098-9
instead. - ^ Tseng, Lisa (2003). "Controversies in Vitamin D Supplementation". Nutrition Bytes. 9 (1).
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1210/jc.2009-1797, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1210/jc.2009-1797
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 7487689, please use {{cite journal}} with
|pmid=7487689
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9323058, please use {{cite journal}} with
|pmid=9323058
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19232159, please use {{cite journal}} with
|pmid=19232159
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20091391, please use {{cite journal}} with
|pmid=20091391
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 3839801, please use {{cite journal}} with
|pmid=3839801
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18290719, please use {{cite journal}} with
|pmid=18290719
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15585802, please use {{cite journal}} with
|pmid=15585802
instead. - ^ a b Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16679080, please use {{cite journal}} with
|pmid=16679080
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1210/jc.2009-1797, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1210/jc.2009-1797
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18593774, please use {{cite journal}} with
|pmid=18593774
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19116321, please use {{cite journal}} with
|pmid=19116321
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8740896, please use {{cite journal}} with
|pmid=8740896
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19303961, please use {{cite journal}} with
|pmid=19303961
instead., - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1172/JCI111995, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1172/JCI111995
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8547833, please use {{cite journal}} with
|pmid=8547833
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19926773, please use {{cite journal}} with
|pmid=19926773
instead. - ^ Tseng, L., (2003) Controversies in Vitamin D Supplementation
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19263699, please use {{cite journal}} with
|pmid=19263699
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20197091, please use {{cite journal}} with
|pmid=20197091
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1017/S0007114508898662, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1017/S0007114508898662
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18458986, please use {{cite journal}} with
|pmid=18458986
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20062904, please use {{cite journal}} with
|pmid=20062904
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20074396, please use {{cite journal}} with
|pmid=20074396
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19753759, please use {{cite journal}} with
|pmid=19753759
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1007/s00198-003-1491-3, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1007/s00198-003-1491-3
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18695076, please use {{cite journal}} with
|pmid=18695076
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17991655, please use {{cite journal}} with
|pmid=17991655
instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.2215/CJN.01220308, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.2215/CJN.01220308
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19444937, please use {{cite journal}} with
|pmid=19444937
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19500727, please use {{cite journal}} with
|pmid=19500727
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19660871, please use {{cite journal}} with
|pmid=19660871
instead.